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Objectives and Achievements  
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This PhD thesis outcome of a hybrid project between the Unit for Mass Spectrometry and 
Proteomics and the Unit for Structural Biology and Biophysics in the Laboratory for Protein 
Biochemistry and Biomolecular Engineering (L-ProBE) (http://www.lprobe.ugent.be). The 
Unit for Mass spectrometry and Proteomics is mainly working on use of mass spectrometry 
and proteomics for the analysis of proteins involved in microbial physiological processes. 
When the PhD project started off, a novel Waters SYNAPT HDMS mass spectrometry has 
been introduced in the lab. This instrument combines the triple quadrupole and Time of 
Flight configuration with a traveling wave ion mobility analyzer which can be used both for 
LC-MS analysis of complex peptide samples and for the investigation of intact proteins and 
the assembly of protein complexes. The Unit for Structural biology and Biophysics focuses 
on the elucidation of the structure function relationships for soluble and membrane associated 
protein using a in-house state-of-the-art platform. Multiple structural biology techniques such 
as X-ray crystallography, small angle X-ray scattering and biophysical techniques such as 
Isothermal Titration Calorimetry, Surface Plasmon Resonance are available to carry out 
interdisciplinary researches. The PhD project aimed to integrate all the available techniques 
as an integrative structural biology approach and to apply it on a set of protein that play an 
important role in the antibiotic resistance and virulence of bacteria.  
Bacteria are reported to be responsible for most of infectious diseases which are worldwide 
responsible for more than 17 million deaths each year, despite the introduction of antibiotics 
in  the  mid  1990’s. The lack of introduction of novel antibiotics and the growing resistance of 
bacteria against a wide range of antibiotics poses a huge challenge for the next decades. 
Multidrug resistance, tolerance and persistence are major causes of failure to respond to the 
conventional antibiotic treatment and further results in prolonged illness, increased mortality 
and higher costs for social security.   
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The PhD project focuses on two aspects of bacterial infections and resistance against 
antibiotics. We used structural biology approaches to understand the mechanisms of bacterial 
persistence by studying a toxin antitoxin system module. Furthermore, we investigated the 
structural assembly of a bacterial type 2 secretion system which is crucial for the 
transportation of virulence factors The objectives and achievements of this thesis are listed in 
the contents below:  
Chapter one (Introduction section A). We reviewed the function and classification of toxin 
antitoxin systems, the latest development of the role of toxin antitoxin systems in biological 
phenomena such as persistence, biofilm formation, and virulence. We conclude with 
perspectives of toxin antitoxin systems as potential targets in the antimicrobial drug discovery.  
Chapter two (Introduction section B). We highlight the advantages and principles of an 
integrative structural biology approach. We focused on the role of biological mass 
spectrometry in this field and discuss different mass spectrometry based approaches including 
Ion Mobility Mass Spectrometry, Chemical crosslinking Mass Spectrometry and Hydrogen 
Deuterium exchange Mass Spectrometry. 
Chapter three. Here we report the results of the integrative structural biology approach 
involving mainly X-ray crystallography, Small angle X-ray scattering and other biochemical 
and biophysical techniques in the study of Shewanella oneidensis HipA-HipB toxin antitoxin 
system We provide an in depth understanding of the HipA-HipB module molecular 
mechanism by analysis of the atomic resolution three dimensional structure.  
Chapter four. We further investigated the Shewanella oneidensis HipA-HipB toxin antitoxin 
system assembly by mass spectrometry including Ion Mobility Mass Spectrometry and 
chemical crosslinking Mass Spectrometry. Complementary insights were observed including 
Objectives and Achievements 
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the transition conformation change of HipA and overall assembly of HipA-HipB and its 
operator DNA complex.  
Chapter five. The integrative structural biology approach was applied in the study of the 
type 2 secretion system of the opportunistic human pathogen Pseudomonas aeruginosa.  We 
focused on two components of this system, i.e. the inner membrane XcpP and outer 
membrane secretin XcpQ. In a collaborative effort with Ruben Van der Meeren from the unit 
for Structural Biology; we obtained multiple restraint data from chemical crosslinking Mass 
Spectrometry, affinity studies and structural modeling. We proposed a transition interaction 
motion of the XcpP and XcpQ periplasmic domain which could complement to understand 
the transportation of the exoprotein from periplasmic space into the type 2 secretion barrel. 
Chapter six. General discussion: conclusion and perspectives of the PhD thesis.   
 
 
Chapter 1 
Introduction Section A 
Toxin-Antitoxin systems: their role in persistence, 
biofilm formation and pathogenicity 
 
 
 
 
 
 
 
 
 
 
The contents of this chapter are adapted from a minireview, accepted for publication in 
Pathogens and Disease (2014): 
Yurong Wen, Ester Behiels, Bart Devreese. Toxin-Antitoxin systems: their role in persistence, 
biofilm formation and pathogenicity.  
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1.1 Abstract 
One of the most pertinent recent outcomes of molecular microbiology efforts to understand 
bacterial behavior is the discovery of a wide range of Toxin-Antitoxin (TA) systems that are 
tightly controlling bacterial persistence. While TA systems were originally linked to control 
over the genetic material, for example plasmid maintenance, it is now clear that they are 
involved in essential cellular processes like replication, gene expression and cell wall 
synthesis. Toxin activity is induced stochastically or after environmental stimuli, resulting in 
silencing of the above mentioned biological processes and entry in a dormant state. In this 
minireview, we highlight the recent developments in research on these intriguing systems 
with a focus on their role in biofilms and in bacterial virulence. We discuss their potential as 
targets in antimicrobial drug discovery. 
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1.2 Introduction  
Almost all bacteria possess genes whose expression can inhibit cell growth and even result in 
cell death when overexpressed, reflecting similarities to eukaryotic programmed cell death or 
apoptosis. Among those, Toxin-Antitoxin (TA) systems contribute largely to the bacterial 
epigenetic regulatory machinery controlling bacterial survival (Engelberg-Kulka et al., 2006; 
Yamaguchi et al., 2011). TA modules usually consist of a stable toxin and a degradation-
prone antitoxin, mostly encoded in an operon, resulting in tight co-transcription and co-
translation of the toxin and antitoxin (Gerdes et al., 1985; Ogura and Hiraga, 1983). The 
cognate antitoxin is either a protein or a small RNA molecule that counteracts the toxin 
activity by acting as a direct inhibitor or by controlling toxin production. They were first 
reported as addiction systems leading to plasmid maintenance. In plasmid-free daughter cells, 
the toxin becomes active by degradation of the instable antitoxin that can no longer be 
replenished, leading to post-segregational killing (Gerdes et al. 1986). Later on, they were 
also discovered in chromosomal genomes where they typically play a role in the stabilization 
of the bacterial chromosome and integrative conjugative elements (Wozniak and Waldor, 
2009). Today, the definition of TA modules is no longer restricted to entities that provide 
control over genetic material, but expanded to a wide range of biological functions including 
growth control, defense against phages, biofilm formation, persistence, programmed cell 
death   (PCD),  general   stress   response  etc…(Wang & Wood 2011, Engelberg-Kulka H et al. 
2006). Basically, toxins within TA modules are proteins whose activity usually leads to 
inhibition of cell growth by interfering with cellular processes such as DNA replication, 
translation, cytoskeletal polymerization, phage infections abortive and cell division (Figure 
1.1).  
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Figure 1.1 Toxin-Antitoxin systems are involved in a broad range of cellular processes. 
The numbers refer to: 1. DNA replication, 2. tRNA related translation, 3. Macromolecular 
synthesis, 4. Cytoskeletal polymerization, 5. Cell wall disruption, 6. Plasmid maintenance 
and 7. Phage infections abortive. The investigation of TA system molecular mechanism could 
lead to the antimicrobial drug discovery dealing with a number of issues inadequately tackled 
and covered by current therapies. 
 
1.3 Function and classification of Toxin-Antitoxin systems  
Given the diversity in structure and function of TA systems, Hayes proposed a classification 
into three major types based on the nature and action of the antitoxin (Hayes, 2003). However, 
recent discoveries resulted in the addition of new classes of TA systems (Masuda et al., 2012; 
Wang et al., 2013).  
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Figure 1.2 Typical mode of action of the 5 classes of Toxin-Antitoxin systems 
 
1.3.1 Type I TA systems (Figure 1.2a)  
The type I TA  system  antitoxins  are  small  regulatory  RNA’s  (sRNA),  typically  of  50  to  200  
nucleotides. Their genes are usually adjacent but antisense to the toxin. Almost all type I TA 
system toxins are small hydrophobic proteins that are assumed to generate pores in the inner 
membrane, disrupting the membrane potential to inhibit ATP synthesis and consequently 
blocking energy-demanding processes such as protein synthesis. 
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The antitoxin sRNA acts by base pairing to the co-transcribed toxin mRNA, blocking 
ribosome binding, followed by degradation of the toxin-antitoxin RNA duplex by RNase to 
suppress the translation of the toxin (Fozo et al., 2008; Van Melderen and De Bast, 2009). 
The type I TA system was first found in plasmids and attributes to plasmid maintenance 
through post-segregational killing. Additional type I TA systems evolved in bacterial 
chromosomes, although no sequence homology to the plasmid-borne systems was reported 
(Fozo et al., 2010). It was indicated that the type I TA systems can also stabilize 
chromosomal segments and maintain integrative conjugative elements to prevent the spread 
of phage infection  (Wozniak and Waldor, 2009).  
The best studied type I TA system, hok/sok was found originally in plasmid R1, but 
homologues were also discovered in other plasmids, e.g. R100, F (Gerdes et al., 1990) and 
later on the Escherichia coli chromosome (Pedersen and Gerdes, 1999). Ectopic hok 
expression leads to cell content leakage and ghost cell formation (Gerdes et al., 1986b). Sok 
RNA is very unstable as it is rapidly degraded by RNase E with a half-life of only 30s. 
Formation of a hok-sok mRNA duplex likewise results in rapid removal by RNase III 
mediated degradation to neutralize the Hok toxicity (Gerdes et al., 1992). Synthetic anti-Sok 
peptide nucleic acid were designed to block the hok mRNA-sok RNA interaction, which 
successfully resulted in the accumulation of Hok protein and bacterial cell death (Faridani et 
al., 2006).  
Well-characterized type I TA system families further include LdrD-RdlD, TisB-IstR, ShoB-
OhsC, SymE-SymR (Faridani et al., 2006; Gerdes and Wagner, 2007). The latter has an 
atypical toxin function; SymE is an RNase. The system is SOS-responsive, and is potentially 
involved in clearance of damaged RNAs (Kawano et al., 2007). Bioinformatics resulted in the 
discovery that loci containing type I toxins are widely spread in bacterial chromosomes. The 
type I TA systems can occur repeatedly within the chromosome, such as LdrD repeats (3-7 
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times), LbsA (2-7 times), the gene encoding the type I toxin with the broadest distribution, 
Hok, is repeated 4-15 times in E.coli (Fozo et al., 2008). The evolution and distribution of 
type I TA system originates from lineage specific duplication (Fozo et al., 2010).  
1.3.2 Type II TA systems (Figure 1.2b). 
In type II TA systems, both the toxin and the antitoxin are proteins. The toxin acts as an 
inhibitor of essential cellular functions such as replication or protein synthesis. The type II 
antitoxin is a DNA binding protein that suppresses the transcription of the toxin. When 
released from the nucleoid, the type II antitoxins are generally labile and can be degraded by 
Lon or Clp proteases (Aizenman et al. 1996; Van Melderen, 1996). Most studies on type II 
TA systems involve MazE-MazF, HipA-HipB, RelB-RelE, MqsR-MqsA, Phd-Doc, and 
VapB-VapC. Typically, the Type II antitoxins form a complex with their toxins sequestering 
the toxins in an inactive form in the nucleoid, although there are exceptions where the toxin-
antitoxin complex does not bind to DNA, e.g. in MqsR-MqsA (Brown et al., 2013).  
MazF-MazE was the first identified chromosomal addiction module in E.coli (Masuda et al. 
1993, Engelberg-Kulka et al. 2005). MazF is an endoribonuclease which can specifically 
cleave mRNA at the ACA site resulting in protein synthesis inhibition (Zhang et al., 2003). 
MazE can be degraded by the ATP dependent ClpAP serine protease. The MazF-MazE 
mediated cell death requires the involvement of the quorum-sensing extracellular death factor 
EDF (Kolodkin-Gal et al., 2007). Similar activities are found in the RelE family, but the latter 
differs from the others as it cleaves only in the presence of the ribosome (reviewed in (Cook 
et al., 2013; Park et al., 2013)). VapC, classified as a PIN domain ribonuclease, was 
originally reported to inhibit translation by cleaving the initiator tRNAfMet (Winther and 
Gerdes, 2011), while Mycobacterium tuberculosis VapC20 is recently demonstrated to cleave 
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the  23SrRNA  in  the  region  were  eukaryotic  toxins  like  α-sarcin and ricin act (Winther et al., 
2013).  
Among the type II TA system family, HipA-HipB is specifically recognized for its role in 
persister formation. The toxin HipA shows sequence similarity to eukaryotic serine/threonine 
kinases. It was originally proposed to phosphorylate elongation factor Tu (EF-Tu) resulting in 
inhibition of protein biosynthesis (Schumacher et al., 2009, 2012). However, this was not 
confirmed, and more recently, glutamyl-tRNA synthetase (GltX) was discovered to be the 
actual substrate (Germain et al., 2013). The HipB antitoxin is a helix-turn-helix protein that 
neutralizes HipA by forming a complex that sequesters HipA in the nucleoid after HipB 
dependent binding to the operators upstream of the HipAB operon, suppressing the 
transcription of HipA (Correia et al., 2006; Schumacher et al., 2009, 2012). 
The Doc toxin from the Doc-PhD system was first reported to acts as an inhibitor of 
translational elongation through binding to the 30S ribosomal subunit. However the protein 
shows similarity to AMPylating enzymes and recently it was discovered that it actually 
evolved to be a phosphorylating enzyme with EF-Tu as the substrate for its kinase activity 
(Castro-Roa et al., 2013). 
The wide distribution and diversity of type II TA systems was recognized in TADB, a type II 
TA system database derived from integrated experimental and bioinformatics approaches 
(Shao et al., 2011). Type II TA systems were both characterized on plasmid and on 
chromosomal genomes and it was proposed that the evolution of type II TA systems from 
plasmid maintenance genes towards the more diverse function of chromosomal distributed 
systems originates from horizontal gene transfer (Leplae et al., 2011). 
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1.3.3 Type III TA systems (Figure 1.2c).  
Here, the toxin protein function is inhibited by directly interacting with pseudoknots antitoxin 
RNA, forming an RNA protein complex. The pseudoknots antitoxin RNA is coded by a short 
tandem repeat upstream of the toxin gene (Blower et al., 2012). ToxI-ToxN, originally 
discovered in the phytopathogen Pectobacterium atrosepticum, was the first type III TA 
system for which a detailed molecular mechanism was revealed (Fineran et al., 2009; Short et 
al., 2013). ToxN is an endoribonuclease sharing structural similarity to type II TA systems 
such as MazF. ToxN is able to cleave ToxI, its own mRNA and other cellular mRNAs 
(Blower et al., 2011). The sRNA antitoxin acts as a specific inhibitor for the cognate toxin. 
The type III TA systems fall in three evolutionary related subfamilies with respectively ToxI-
ToxN, TenpI-TenpN and CptI-CptN being the prototypic representatives (Blower et al., 
2012). So far, all seem to share potential function to abort phage infection.  
1.3.4 Type IV and V TA system (Figure 1.2d and 1.2e).  
These are recently two new discovered TA systems modules. In the type IV TA system, the 
toxin CbtA inhibits the polymerization of the cytoskeletal proteins MreB and FtsZ which are 
essential in cell division. The antitoxin protein CbeA (YeeU) interferes by directly binding 
with the toxin targets MreB and FtsZ rather than forming a toxin-antitoxin complex as in 
other systems (Masuda et al., 2012). In the type V TA system, the antitoxin GhoS was 
identified as an endoribonuclease and cleaves specifically the toxin GhoT mRNA, which 
encodes a membrane lytic peptide (Wang et al., 2013). 
1.3.5 Other TA systems 
With the increasing availability and analysis of prokaryotic genomes, we expect novel TA 
modules to be discovered and the current classification system might require revision. A 
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recent large scale cloning experiment pointed already in this direction (Sberro et al., 2013). 
During finishing the draft of this review, this was illustrated by the description of the 
Caulobacter crescentus SocAB system that has a mode of action not included in the current 
classification criteria of TA systems. SocB toxin blocks replication elongation and the SocA 
antitoxin acts as a proteolytic adapter for protease ClpXP dependent degradation of SocB 
(Aakre et al., 2013). 
1.4 Toxin-Antitoxin systems and persistence 
TA systems are widely distributed in bacteria. At least 36 TA systems are discovered in the 
E.coli K-12 genome and as many as 65 TA systems in Mycobacterium tuberculosis H37Rv 
(Shao et al., 2011; Yamaguchi et al., 2011). The observation of large pools of TA systems in 
pathogens like Mycobacterium tuberculosis was reported to increase the capacity of entering 
the persistence state, further resulting in multidrug tolerance (Ramage et al., 2009). 
Persistence  was   already   described   in   the   early   1940’s   during   studies   of   the  mechanism   of  
penicillin when it was observed that a small population of persister cells survived as dormant 
cells, different from traditional antibiotic resistance mechanisms (Bigger, 1944; Hobby et al., 
1942) . The characteristics used to define the persister phenotype are still constantly updated 
and include dormancy, multidrug tolerance and a stochastic nature. Persistence can be 
described as the ability of a few cells within a genetically homogenous population to survive 
different types of stress (Scherrer and Moyed, 1988). These persisters are not mutants but 
phenotypic variants of the wild type.  They show the same minimal inhibitory concentration 
(MIC) for antibiotic treatment as the rest of the population and upon regrowth they are as 
sensitive as is the original population. Persistence should thus be regarded as a population 
phenomenon and not as an individual trait, and is characterized by a biphasic killing pattern 
in a time- or dose-response experiment: at first, fast killing is observed, which is followed by 
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survival of a small fraction that is virtually insensitive to increasing antibiotic concentrations 
(Moyed and Bertrand, 1983; Moyed and Broderick, 1986). A small number of persistent cells 
seems to present in any bacterial culture, very small (less than 0.1%) in log phase cells up to 
1% of the population in stationary phase cells, reflecting a stochastic induction of the 
persistence mechanism (Balaban et al., 2004). However, .persistence is dramatically 
increased upon arrest of protein synthesis upon environmental stimuli (Kwan et al., 2013). 
The environmental conditions to stimulate formation of persister cells are diverse and include 
antibiotic pressure, starvation, oxidative stress, extreme pH and temperature and the host 
immune system (Wang and Wood, 2011). 
 It took until 1983 to identify the first gene that is involved in persistence. In E.coli K-12, it 
was found that the hipA7 allele showed a ratio of 10-2 of persisters upon ampicillin treatment, 
whereas for the wild type strain this ratio is as low as 10-5 to 10-6 (Moyed and Bertrand, 1983). 
Moyed and his coworkers systematically described the persister phenomenon (Scherrer and 
Moyed, 1988) and explored the hip gene structure and mechanism of hipA autoregulation 
(Black et al., 1991, 1994). HipA7 is the result of a double mutation (G22S, D291A) and has 
similar effects as overexpression of HipA (Korch et al., 2003).  
Despite the evidence for the involvement of TA systems in the development of bacterial 
persistence, the effects of deletion of a single TA system on persistence are variable (Keren et 
al. 2004, Kim & Wood 2010). Deletion of tisB, mqsR or hipAB has a dramatic effect on the 
level of persistence, whereas deletion of mazEF does not. The effect is more pronounced in 
stationary-phase or biofilm cells where there is a higher frequency of persistence formation. 
Redundancy of TA systems, in particular of the type II class, on most bacterial genomes 
explains this phenomenon. For example,  progressive decrease of survival upon antibiotic 
treatment was only observed when stepwise up to 10 endoribonuclease encoding TA systems 
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were disrupted in E.coli, ultimately resulting in a 100-200 fold reduction compared to the 
wide type E.coli of persistence frequency (Maisonneuve et al., 2011).   
Induction of TA system activity is modulated by the signaling nucleotide (p)ppGpp acting via 
a cascade involving Lon protease, inorganic phosphate and other stress induced signaling 
pathways. Stochastic variation leads to a higher level of (p)ppGpp in a subset of 
exponentially growing cells that switch to a slow growth mode and activate the TA systems 
(Amato et al., 2013; Maisonneuve et al., 2013). Furthermore, Kwan et al. proved that 
chemical inhibition of protein synthesis also increases the persister-like cell formation. This 
work included an important warning, as many antibiotics like fluoroquinolones act on the 
protein synthesis machinery and could provoke the formation of cells that develop persistence 
to other drugs, for example in combination therapies (Kwan et al., 2013). 
Recent work revealed that the autoregulation of TA systems, which involves conditional 
cooperativity, results in a threshold phenomenon that could explain the spontaneous 
(Cataudella et al., 2012) and stochastic persister cell formation (Gelens et al., 2013; Rotem et 
al., 2010). Further, Fasani and Savageau provided a model explaining that the redundancy of 
type II TA systems in prokaryotic genomes increases the frequency of persister cell formation 
and how the TA systems give rise to a bimodal population of persisters and normal cells 
(Fasani and Savageau, 2013).   
1.5 Toxin-Antitoxin systems and biofilm formation 
Most bacteria in the environment live in biofilms, multispecies consortia embedded in an 
extracellular matrix adhering to both biotic and abiotic surfaces (Stewart and Franklin, 2008). 
Biofilm formation is a well-controlled developmental process with distinctive steps including 
initial attachment to the surface, maturation of the biofilm and detachment of cells and 
dispersal (Hall-Stoodley and Stoodley, 2002). Many chronic infections are associated with 
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the biofilm formation capability of the pathogenic bacteria (von Rosenvinge et al., 2013). 
Examples of biofilm-associated infections include cystic fibrosis (CF) by Pseudomonas 
aeruginosa (Mulcahy et al., 2013) and tuberculosis (TB) by Mycobacterium tuberculosis 
(Bjarnsholt, 2013). The capability to form biofilm is demonstrated to be the main strategy 
that the pathogenic bacteria like Pseudomonas use to survive against the host immune 
defense (Rybtke et al. 2011).  
Besides the involvement of pathogenicity development and persistence, biofilm also plays an 
important role in engineering applications. The ability that Shewanella oneidensis MR-1 can 
respire on the insoluble metal substances is dependent on its biofilm formation capacity. 
Researchers express high interest in Shewanella oneidensis MR-1 for its role in 
biogeochemistry, its potential for bioremediation of heavy metals and aromatic compounds, 
nanowire synthesis application as well as for its use in microbial fuel cells (Beveridge et al., 
2009; El-Naggar et al., 2010; Heidelberg et al., 2002). All of these applications rely on the 
potential of the organism to form biofilms at inorganic surfaces. 
It is widely accepted, mainly through the work of Kim Lewis and co-workers, that biofilms 
provide a shelter for the survival of persistence cells. Upon antibiotic treatment, the majority 
of cells are killed, leaving only persister cells that survive. The immune system is supposed to 
clear these cells, but fails to reach biofilm embedded cells that then may repopulate the 
biofilm. This is followed by the release of planktonic cells that can spread and cause 
symptoms (Lewis, 2007, 2010).  
However, a direct role for TA systems in controlling the transformation of planktonic to 
biofilm cells has long been debated. The first TA system that was reported to play a direct 
role in biofilm formation involved the E.coli b3022 gene product, later renamed as MqsR 
which forms a type II TA system with MqsA (Kasari et al., 2010; Ren et al., 2004). This 
system cross-talks between the AI-2 dependent quorum-sensing system and the regulation of 
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motility (Barrios et al., 2006). MqsA represses also the expression of the general stress 
response regulators RpoS and CsgD, leading to reduced formation of the signaling nucleotide 
c-di-GMP, curli production and overall reduction of biofilm formation (Soo and Wood, 2013). 
Upon degradation of MqsA by Lon protease, triggered by oxidative stress, a switch to the 
biofilm mode of growth is made (Wang et al., 2013).   
It is suggested that programmed cell death could be an altruistic mechanism to allow a small 
subpopulation of biofilm cells to survive by releasing essential nutrients in the biofilm 
community where diffusion is limited. As already mentioned, the TA module mostly linked 
to PCD in E.coli is MazEF. Indeed, KO mutation of mazEF, as well as of yafQ/dinJ, was 
reported in different studies to result in a prominent decrease in biofilm formation (Kim et al. 
2009, Kolodkin-Gal et al. 2009). It is suggested that expression of mazEF is a stress response 
to cellular damage and results in a reversible bacteriostasis (Bayles, 2013). However, if the 
cellular damage, e.g. DNA damage, enters a certain, yet poorly understood, threshold, the cell 
enters into PCD. This is followed by apoptotic-like processes, for example the activation of 
holins, leading ultimately to cell lysis (Rice et al., 2007) 
Also other TA systems are often found differentially regulated when performing 
transcriptomic or proteomic comparisons between planktonic and biofilm cells.  For example, 
several TA systems are upregulated in biofilm cells in Treponema denticola, an oral 
spirochaete strongly associated with chronic periodontitis (Mitchell et al., 2010). In the 
HipA-HipB TA system, interruption of the HipA gene by transposon mutagenesis could 
decrease biofilm formation in Shewanella oneidensis MR-1 (Theunissen et al., 2010). This 
was confirmed in E.coli where it was related to the release of extracellular DNA (eDNA) 
which is essential as an adhesion molecule for the biofilm formation (Zhao et al., 2013). 
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1.6 Toxin-Antitoxin systems and virulence 
TA systems are not only involved in general bacterial physiological processes such as the 
general stress response, persistence and biofilm formation but also have a direct impact on 
the pathogenicity of bacteria.  It was recently discovered that a surprising correlation exists 
between the number of TA modules in the genome and the virulence capacity of bacteria 
(Georgiades and Raoult, 2011). TA systems are omnipresent on mobile genetic elements that 
have been found in many pathogenic bacteria and that are involved in antibiotic resistance 
and virulence as pathogenicity islands (Ma et al., 2013). One of the main functions of TA 
systems is to stabilize and maintain the plasmid population, such as the mvpA-mvpt (VapBC) 
on a Shigella flexneri virulence plasmid Pmysh6000 (Sayeed et al., 2000) and HigBA in 
Proteus vulgaris (Hurley and Woychik, 2009).  Deletion of VapBC homologues in non-
typeable Haemophilus influenzae leads to strong reduction of virulence in tissue and animal 
models for otitis media (Ren et al., 2012). A remarkable example of the ambiguous effect of 
antibiotic treatment involves VapC in Ricketsia : VapC is released by the bacterium upon 
chloramphenicol treatment and causes host cell apoptosis, presumably via its RNase activity 
(Audoly et al., 2011). 
Type II TA systems with toxin endoribonuclease activity are involved in the regulation of 
virulence factors expression. The S. aureus MazF recognizes specific pentad sequences 
which are overrepresented in proteins involved in virulence. More specifically, it is involved 
in the degradation of the mRNA for SraP, a protein directly involved in host-pathogen 
interaction (Zhu et al., 2009). Expression of this protein is growth phase dependent, 
presumably under control of the MazE antitoxin. A similar role for tuning the production of 
virulence factors was found in Clostridium difficile (Rothenbacher et al., 2012). Remarkably, 
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a MazEF TA system has been demonstrated on plasmids obtained from all vancomycin 
resistant enterococci (VRE) (Moritz and Hergenrother, 2007). 
The  3   component  TA   system  ω-ε-ζ   system  was   discovered   from  a   clinically isolated gram 
positive pathogen Streptococcus pyogenes plasmid pSM19035, later it was also identified on 
other   pathogenic   gram   positive   bacteria’s   multiple   resistance   plasmids   such   as   found   in  
Enterococcus faecalis and E. faecium (Moritz and Hergenrother, 2007).   The   ω-ε-ζ   was  
reported to contribute to their virulence and proved to stabilize the plasmid involved in 
resistance to erythromycin and lincomycins (Mutschler and Meinhart, 2011).  
Some type I toxins are described to be directly involved in host cell lysis. The S. aureus 
Pepa1 toxin is a pore-forming peptide that can cause bacterial cell death. It is typically 
released from its SprA antitoxin upon oxidative stress for example after internalization of the 
Staphylococcus in the phagolysosomes. This is suggested to be an example of altruistic 
behavior, as the peptide can also drive erythrocyte lysis, resulting in release of slowly 
dividing cells that thus can escape the immune system (Sayed et al., 2012). 
1.7 Toxin-Antitoxin systems and antimicrobial drug 
development 
Due to the limited effectiveness of current drugs and the increasing multidrug tolerance and 
resistance, there is a growing need for novel antimicrobial agents. The targets of the TA 
toxins are mostly involved in biological processes such as DNA replication, mRNA synthesis, 
macromolecular synthesis, cell wall synthesis, phage infection and cytoskeletal 
polymerization. There is a remarkable overlap between these and antibiotics targets (Table 
1.1, Figure 1.3). This, together with involvement of TA systems in programmed cell death 
indicates that investigation of TA systems can provide alternative antimicrobial strategies 
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(Park et al., 2013). Structural biology efforts to study TA systems can direct antibiotics 
discovery both by rational drug design (Mandal et al., 2009) or prodrug screening. It should 
be realized that the redundancy of TA systems and other pathways to persistence formation 
form a serious bottleneck to directly use them as drug targets (Lewis, 2012, 2013). However, 
understanding their mode of action could lead to the discovery of better suited downstream 
processes as was recently shown by the use of acyldepsipeptides to continuously activate 
ClpP, even in the absence of ATP generating processes in dormant cells (Conlon et al., 2013).  
Breaking the balance of toxin-antitoxin levels offers the possibility to induce suicide in 
bacteria.  Derived from CcdB, which targets DNA gyrase resulting in DNA fragmentation 
and cell death in E.coli, a peptide was synthesized that inhibits the DNA gyrase and other 
topoisomerases killing the bacteria (Trovatti et al., 2008).  
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Figure 1.3 Targets of antibiotics and Targets of Toxins. The procedures involved in 
antibiotic killing and the growth arrest strategy of the toxins are highly similar. Thus the 
investigation of Toxin-Antitoxin systems could lead to the antimicrobial drug discovery. 
Figure modified and adapted from Kim Lewis Nature Reviews Drug Discovery (Lewis, 
2013). 
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Table 1.1 List of molecular functions in which Toxin-Antitoxin systems are involved. The rem
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In  the  ω-ε-ζ  TA  system,  the  toxin  ζ  was  shown  to  phosphorylate  the  peptidoglycan  precursor  
UNAG, further resulting in the competitive inhibition of MurA which plays an important role 
in the peptidoglycan synthesis (Mutschler et al., 2011).   The   enzymatic   product   of   toxin   ζ,  
UNAG-3P was described to be a potential lead agent for a new broad spectrum antibiotic 
(Mutschler and Meinhart, 2011).  
More TA system applications deal with the endoribonucleases type of toxins other than 
involved in the antibacterial drug discovery include antiviral gene therapy and recombinant 
protein technology (Chono et al., 2011; Shapira et al., 2012; Suzuki et al., 2005). Antiviral 
therapy is based on the fact that some endoribonucleases, e.g. MazF also induce eukaryotic 
cell death. Bringing mazF under an HIV specific regulator provokes cell death of infected 
cells (Chono et al., 2011). Alternatively, MazF was introduced in a so-called zymoxin, in a 
fusion of rationally designed antitoxin peptides, a viral protease cleavage site. Upon infection, 
the viral protease will release the MazF protein (Shapira et al., 2011, 2012). 
 
 
 
 
 
 
 
 
 
Introduction Section A: Toxin-Antitoxin System 
25 
1.8 Conclusion and Perspectives 
After more than two decades of investigation in TA systems, their involvement in a broad 
range of microbial phenomena is obvious. Understanding the role of the bacterial TA systems 
gave dramatic insight to understand the molecular mechanisms of bacterial stress response, 
and how persistence and biofilm formation are induced. TA systems control therefore 
mechanisms that contribute largely to the failure of the current antibiotics. The investigation 
of TA systems starts to raise examples of how the study of fundamental mechanisms evolves 
to biotechnological and medical applications such as antimicrobial drug discovery. 
Nevertheless, in the pace with more and more characterized and uncharacterized TA systems 
were discovered and their molecular mechanisms will be explored, the detailed function and 
evolution of each TA system will be revealed. Definitely, the investigation of TA systems 
will lead and play a crucial role in the microbiology field. 
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2.1 Introduction 
Since the discovery of the double helix structure of DNA in 1953, the whole genome of more 
than 10000 organisms was sequenced; including bacteria, archaea, eukaryote and also the 
DNA sequence of many viruses, phages, viroids, plasmids and organelles was completely 
determined (http://www.ncbi.nlm.nih.gov/genome). In 2003, as one of the major milestones, 
the human genome sequence was completed by the Human Genome Project (HGP), with 
efforts from laboratories all over the world (http://www.genome.gov/). The number of human 
protein coding genes is estimated to be between 20000 to 25000 (International Human 
Genome Sequencing Consortium, 2004; Lander et al., 2001; Venter et al., 2001).  Compared 
to the number of genes of other organisms, the number of human genes surprisingly does not 
corroborate the relative complexity of human life. It has been recently revealed that the 
biological complexity is correlated with the Protein-Protein Interaction (PPI) network, rather 
than simply with the total number of proteins. The number of interactions in human cells is 
estimated to be around 650000, which is tenfold higher than for the fruit fly Drosophila 
melanogaster which has a similar number of genes as human (Duan, 2002; Hart et al., 2006; 
Stumpf et al., 2008). The  Protein-protein Interaction Network (PIN) turns out to be relevant 
to understand the functional and the evolutionary properties of biological systems (Jin et al., 
2013).  
A living cell has a wide range of PPIs of structural and functional relevance. To understand 
the function of macromolecular assemblies, it is essential to explore the characteristics of the 
individual macromolecules, and then to study their stoichiometry, shapes, structures and 
finally their assemblies (Sharon, 2010). To achieve this, it is necessary to study subsequently 
from each component of the assembly the amino acid sequence, the secondary structure, the 
stoichiometry, the affinity and ultimately the high resolution 3-dimentional structure. Thanks 
to developments in the atomic resolution technologies such as X-ray crystallography and 
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Nuclear Magnetic Resonance (NMR), the number of proteins of which the three dimensional 
structure has been determined will reach a total number of 100000 in the year 2014 as can be 
found in the Protein Data Bank (PDB) (http://www.rcsb.org/pdb/home/home.do). However, 
compared to the number of genes in the GenBank database 
(http://www.ncbi.nlm.nih.gov/genbank/), there is still a difference of two orders of magnitude. 
Furthermore, over 85% of the structures deposited in PDB are monomers or homomers, 
whereas in a living cell proteins mostly function as oligomers and are involved in heteromeric 
complexes. By way of example, there are approximately 6 unique interactions per protein in 
Saccharomyces cerevisiae (Reguly et al., 2006), although the interactions partners are largely 
unknown. Unfortunately, PINs occur at relative low concentration within physiologically 
relevant samples. Especially the approaches applied to determine 3-dimentional structures 
such as X-ray crystallography, NMR spectroscopy or other techniques require large amounts 
of sample or long acquisition time and poorly address certain groups of proteins, e.g. 
membrane associated proteins. All those features of the traditional approaches make the 
determination of the macromolecular assemblies to be a major challenge and there are many 
hurdles on the way to get the job done in one step.  
At present, a macromolecular study cannot be achieved by a single technique and thus 
requires the development of so-called   “Integrative   Structural   Biology”   (ISB),   an   approach  
which combines multi-source data information to achieve the determination of biologically 
relevant macromolecular assembly structures. Such multiple biophysical techniques mainly 
include X-ray crystallography, nuclear magnetic resonance (NMR), Small Angle X-ray 
Scattering (SAXS), Electron Microscopy (EM), Mass Spectrometry (MS), Atomic Force 
Microscopy (AFM), Förster Resonance Energy Transfer (FRET), and computational 
modeling (Figure 2.1) (Karaca and Bonvin, 2013; Ward et al., 2013).  
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Figure 2.1 Principle of Integrative Structural Biology approaches. Models of 
macromolecules and their complexes can be constructed by combining different types of 
information generated by various experimental and theoretical techniques (gray box). The 
data are converted into spatial restraints, which are combined into a scoring function that 
guides sampling algorithms to obtain a detailed structural model. Adapted from (Ward et al., 
2013) 
 
The individual data source can generate information on the different (spatial) restraints of the 
biological macromolecular assembly. Hence the combination of all the restraints will lead to 
the final model through an integrative modeling approach.  
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In the last decade, the development of mass spectrometry applications in the field of 
Integrative Structural Biology allowed to establish the bridge between the partial high 
resolution structure of subunits of a complex and the macromolecular assembly of the 
multiple subunits.  The  discovery  of  electrospray  ionization  added  the  wings  to  the  “molecular  
elephant”  which  makes   the   analysis   possible   of   intact   proteins   and   of   their   assembly  with  
other proteins, DNA, RNA or small chemicals (Fenn, 2003). Together with MALDI, this soft 
ionization technique has contributed to the widespread use of mass spectrometry both in the 
academic and industrial fields.  
Mass spectrometry, a technology that allows to determine the mass-to-charge (m/z) ratio of 
ionized molecules, has mainly played an essential role in Proteomics for its capacity to 
measure the masses of tryptic fragments of proteins with great accuracy and to subsequently 
identify the peptides by database searches (Aebersold and Mann, 2003). The quantitative 
nature of mass spectrometry allowed using this method to determine gene expression levels at 
the protein level. However, since its early days, electrospray ionization has also been used to 
establish information on protein-protein and protein-ligand interactions. Indeed, it was shown 
that non-covalent interactions can be maintained during ionization, allowing to determine the 
mass of the complex (Loo, 1997). Most recently, the development of high resolution mass 
spectrometry and its combination with ion mobility measurements, chemical crosslinking 
methods, hydrogen/deuterium exchange, affinity purification and computational processing 
have shed light on the structure of macromolecular assemblies. Here we summarize the 
principles of these technologies and their applications in the field of Integrative Structural 
Biology. 
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2.2 Mass Spectrometry and Ion Mobility  
Ion Mobility spectrometry (IMS) is a technique that allows to separate ionized molecules 
based on their different mobility in a neutral carrier gas under a weak electric field (Kanu et 
al., 2008). IMS was first developed to be applied on small chemical molecules such as drugs 
and explosives. However, it can also be applied to large molecules such as intact proteins and 
macromolecular assemblies for use in the field of structural biology (Jurneczko and Barran, 
2011; Konijnenberg et al., 2013). The MS instrument that is available for the IM 
measurement contains an ion mobility separation unit apart from the normal ion generation, 
ion selection and ion mass analysis MS components (Figure 2.2a). Different ion mobility 
results in a different drift time in the drift tube; compact ions will move faster than extended 
ones which will result in a shorter Arrival Time Distribution (ATD) (Figure 2.2b). From this 
drift time, the collision cross section (CCS) can be generated corroborating the shape of the 
ions (Equation 1) (Bohrer et al., 2008).  
 
Equation 1:  z is the charge on the ion, kb is the Boltzmann constant, and P and T are the 
pressure and the temperature. The mass of the ion and the buffer gas are also considered, 
where mI represents the mass of the ion of interest and mN represents the mass of the buffer 
gas. The final variables are the neutral number density of the buffer gas N, L is the length of 
the drift tube, tD is the time the ion requires reaching the detector, and the cross-section of the 
ion itself Ω. 
 
Introduction Section B: Mass Spectrometry 
43 
In combination with a Time-of-Flight analyzer, the IM-MS data generates a three 
dimensional spectrum, including the m/z ratio, the intensity and the drift time of ions (Figure 
2.2c).  
The combination of ESI and IM-MS can thus be used to analyze intact macromolecular 
assemblies, gaining insight into protein interactions networks and to architectural models 
(Robinson, 2012; Sharon and Robinson, 2007; Zhou and Robinson, 2010).  Initially, the 
debate on protein stability in vacuum instead of in solution involving the contribution of 
hydrophobic forces was projected. Later, it was proven that van der Waals attractive forces 
can provide sufficient stability to retain complex assemblies in the gas phase, and that the loss 
of water molecules is compensated through the formation of hydrogen bonds between protein 
residues as suggested by molecular dynamics simulations (van der Spoel et al., 2011).  The 
many successes in the ESI-IM-MS approach have shown that the native-like assembly of 
complexes is retained without disrupting the ternary macromolecular complex structure in the 
milli-second timescale when the complex is transferred into the gas phase (Marcoux and 
Robinson, 2013). Therefore, ESI-IM-MS is a very powerful approach to investigate 
macromolecular assemblies.  
The ESI-IM-MS technique has been applied to solve the assembly not only of soluble protein 
complexes but also of membrane protein complexes which need to be stabilized by detergents. 
Initially, the technique was indeed used to determine the compositing units and the 
stoichiometry of soluble proteins and their ligand-binding properties (van Duijn et al., 2009; 
Gold et al., 2011; Zhou et al., 2008). Recently, ESI-IM-MS was successfully applied to 
investigate membrane proteins as huge and complicated as V-type ATPase with its lipid and 
nucleotide binding characteristics (Barrera and Robinson, 2011; Zhou et al., 2011), and an 
ABC transporter revealing its drug-binding properties and information on its conformational 
changes (Marcoux et al., 2013). 
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Figure 2.2 Ion Mobility Mass Spectrometry Theory. a. A schematic view of Quadrupole-
Ion Mobility Time of Flight Mass Spectrometry instrument (Synapt G2, Waters) B 
enlargement view of the Ion Mobility Separation part. Adapted from (Zhong et al., 2011). b. 
Besides the separation through different m/z ratio, the ions can also be distinguished due to 
distinct arrival time distribution caused by their different shape in the buffer gas, thus 
generating a third dimension ion separation capacity. Adapted from Bowers Group Website. c. 
Example of 3-dimensional view of IM-MS separation generated from DriftScope (Waters). 
 
Most recently, the CCS restraints generated from ESI-IM-MS were found to benefit modeling 
of the overall architecture of multiprotein complex assemblies at low resolution, and has also 
been shown to moderately correlate with high resolution X-ray analyses (Hall et al., 2012; 
Politis et al., 2010).  Therefore, the ESI-IM-MS approach has shown the potential to generate 
low resolution models of macromolecular assemblies. To improve resolution and the false 
discovery rate (FDR) of structural models generated from the CCS restraints, one of the main 
challenges which remains to be solved is to develop more accurate and standard gas phase 
CCS calibration methods (Bush et al., 2010). Besides being useful in the study of protein 
complex assemblies, a nice confirmation of the potential of the ESI-IM-MS approach dealing 
with macromolecular assembly study is the successful investigation of the intact viruses and 
virus capsids assemblies which are as large as 18MDa using only minor modifications of 
commercially available MS instrument (Snijder et al., 2013; Uetrecht et al., 2008). With the 
breakthrough of high resolution and sensitive commercial MS instrumentations, the ESI-IM-
MS technology will in future be more widely used in Integrative Structural Biology.   
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2.3 Mass Spectrometry and Chemical Crosslinking 
Chemical crosslinkers are compounds that are used to covalently connect proteins that form 
otherwise complexes via weak non-covalent interactions that cannot be sustained during 
sample preparation and purification for biophysical analysis. It are mostly small chemical 
molecules having two reactive functional (bifunctional) groups (Sinz, 2003, 2006). These 
groups can either be homobifunctional or heterobifunctional (Figure 2.3).  
 
Figure 2.3 Examples of heterobifunctional and homobifuntional crosslinkers. a. The 
heterobifunctional crosslinker Sulfo-SMCC first labels primary amines with a cysteine 
reactive functional group, maleimide. Maleimide targets reduced sulfhydryls such as those 
found in the side chain of a cysteine residue. b. the homobiofunctional crosslinker DSS reacts 
with primary amine groups from both sides resulting in amine to amine conjugation. Adapted 
from Thermo Scientific Pierce.  
 
There is a spacer between those two reactive groups which should correspond with the 
distance between the two residues to be crosslinked. The spacer can also be used as a reporter 
or label for further enrichment and identification of crosslinked products. Mostly, 
bifunctional crosslinkers can generate three types of crosslinked products: single reactive 
group crosslinked peptides (type 0); intra crosslinked peptides (type 1) and inter crosslinked 
peptides (type 2). The type 1 and type 2 crosslinked peptides are the most valuable ones since 
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they provide significant information on the distance between two different residues, which 
lead to restraints useful in structure determination and macromolecular architecture modeling 
(Paramelle et al., 2013; Zybailov et al., 2013).  The reactivity and selectivity of a crosslinker 
are essential for the experimental success. At present, there are more than 100 crosslinkers 
reported, with most of them being commercially available. Those crosslinkers differ in 
reactive groups, in length of spacer and in having or not having a specific reporter, such that a 
widespread range of crosslink experiments can be carried out (Sinz, 2003, 2006).  
Recent improvements in mass spectrometric technology have generated a renewed interest in 
chemical crosslink approaches. Indeed, after selection of suitable crosslinkers, a Top-down or 
Bottom-up approach can be applied to analyze crosslinked sample followed by high 
resolution MS analysis, a method referred to as XLMS The principle of the XLMS approach 
is described in (Figure 2.4).  After crosslinking the proteins, mostly a proteolytic digestion is 
performed to cleave the protein in peptides, followed by LC-MS/MS to identify the cross-
linked peptides. Enrichment of the crosslinked peptides is crucial to improve MS detection, 
since the crosslinked peptides mostly have very low abundance in the digestion mixtures. 
Strategies implying size exclusion chromatography (SEC), chemical resin pull down 
enrichment, or reporter affinity purification significantly increase the sensitivity of 
crosslinked peptides detection (Buncherd et al., 2012; Leitner et al., 2012a; Weisbrod et al., 
2013). 
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Figure 2.4 Chemical Crosslink Mass Spectrometry approach. A protein complex is 
crosslinked with selective crosslinker, followed by proteolysis prior to high resolution 
LCMS/MS analysis. MS data is interpreted and crosslinked peptides with distance restraints 
are generated for structural models selection. Adapted from Dalton Mass Spectrometry Lab. 
 
Crosslinked peptide identification has always been a big challenge in the XL-MS 
investigations because a crosslink is essentially different from a classical post-translational 
modification (PTM). Initially, the crosslink identification algorithms could only be applied in 
small scale analyses, examples of such algorithms are: xComb (Panchaud et al., 2010), 
X!Link (Lee et al., 2007), MassMatrix (Xu et al., 2010). Besides the challenge to increase the 
amount of a MS-detectable crosslinked peptide, the accurate and efficient identification of 
crosslinks in large scale proteomes and the improvement of false discovery rate of this 
identification have become an essential problem (Tabb, 2012). Recently, the introduction of  
novel algorithms presented in software tools like Xquest, Xprophet 
(http://prottools.ethz.ch/orinner/public/htdocs/xquest/) (Walzthoeni et al., 2012) and Plink, 
Pfind (http://pfind.ict.ac.cn/software/pLink/index.html) (Yang et al., 2012) has dramatically 
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made the XLMS approach more accessible for routine applications, effectively improving the 
false discovery rate, using appropriate  isotope labeled crosslinkers. 
The XLMS approach is mostly been use to unravel the binary interactions in protein 
complexes,  being combined with other biophysical techniques, such as X-ray 
crystallography, Electron Microscopy (EM) and Small Angle X-ray Scattering (SAXS)  thus 
contributing to  three dimensional model building (Rappsilber, 2011; Stengel et al., 2012). 
Recently, the distance restraints generated from XLMS were applied to improve the 
refinement of existing X-ray diffraction data of the eukaryotic chaperonin protein complex 
TRiC/CCT; significantly improving the atomic resolution model fitting, with 6% Rfree 
optimization (Leitner et al., 2012b). The combination of XLMS with affinity purification (AP) 
and Electron Microscopy (EM) was successful to determine the structural interaction network 
of human protein phosphatase 2A (PP2A) and construct the three dimensional model of the 
TCP1 ring complex (TRiC) chaperonin interacting with the PP2A regulatory subunit 2ABG 
(Herzog et al., 2012).   
With both technological and informatics improvements described above, the XLMS approach 
extended from in vitro analyses to levels comparable to  physiological relevant in vivo 
conditions, allowing to address the whole cell proteome interactome (Zheng et al., 2011).  
Most recently, Real-time Analysis for Crosslinked peptide Technology (ReACT) was 
developed which successfully identified 708 unique crosslinked peptide pairs with less than 5% 
false discovery rate in E.coli (Weisbrod et al., 2013).  By further improvement of the XLMS 
approach, sample preparation techniques, design of new crosslinker molecules and advanced 
database search strategies, the ultimate goal of detecting proteome wide protein interaction 
networks and topological analyses are achievable. All the above mentioned breakthroughs in 
XLMS, including the enrichment of crosslinked peptides, higher mass accuracy and 
improved sensitivity of MS instrumentation, more accurate and efficient crosslink 
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identification algorithms for large scale proteomes, and the decrease in false discovery rate 
have leveled up the technique of XLMS in biological applications, especially in the field of 
integrative structural biology of macromolecular assemblies.   
2.4 Mass Spectrometry and Hydrogen Deuterium Exchange 
Since its introduction in the 1990s, Hydrogen Deuterium Exchange Mass Spectrometry 
(HDXMS) has been found to be a powerful approach to probe protein conformational 
dynamics and protein interactions (Katta et al., 1991; Katta and Chait, 1993). The method 
uses stable isotope labeling with deuterium to trace the rate at which the hydrogen atom of 
the protein backbone amide bond undergoes exchange. The hydrogen/deuterium exchange 
rate is highly dependent on the degree of hydrogen bonding, and therefore reflects the protein 
conformational mobility, hydrogen bond strength and solvent accessibility. HDXMS can thus 
provide information on  protein conformational changes, and efficiently catch information on 
the thermodynamics and kinetics of protein unfolding at the moment of equilibrium (Jaswal, 
2013).  
Experimentally, the approach of HDXMS includes protein labeling, denaturation of the 
samples, protein fragmentation, LC-MS, and interpretation of the data in context of the 
structure (Figure 2.5) (Brock, 2012). Although there are quite some discussions  about the 
method concerning aspects of reproducibility, digestion efficiency, protein size and resolution, 
HDXMS has been used and successfully applied in biopharmaceuticals studies, the 
development of  formulation, and in protein interaction studies (Iacob and Engen, 2012). 
HDXMS application areas also include the study of excited states, redox states, catalytic 
transition states, substrate recognition, metastable states, assembly of macromolecular 
complexes, aggregation, enzyme activation and regulation, and in the interaction studies of 
protein with small molecules (Brock, 2012). Most recently, it was also involved in the 
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structure-function investigation of membrane proteins of the G protein coupled receptor 
(GPCR) family, and drug discovery studies (Katritch et al., 2013; Pacholarz et al., 2012). 
After two decades of development as routine analytical technique, HDXMS has been applied 
in a large number of applications, providing complementary information. However, although 
still a lot of features need to be explored such as the origin of some HDX signals, attained by 
other methods, the HDXMS will provide very promising and meaningful insights in protein 
assembly research. 
 
Figure 2.5 Hydrogen Deuterium Exchange Mass Spectrometry approach. Typical 
fragmentation HDXMS, data analysis, and interpretative workflow. Isotope exchange is 
initiated by dilution into D2O. After a set period, the sample is quenched by dilution with 
denaturant and lowering of the pH and temperature. This is followed by proteolysis and 
LCMS. Deuteration levels are extracted from the mass spectra and interpretation of the data 
is performed in the context of available structures and other biophysical data. Adapted from 
(Brock, 2012) 
 
Besides the techniques of IM, XL and HDX mass spectrometry discussed above, some other 
techniques have also been applied to study the integrative proteomics and to generate 
structural restraints. Such techniques include, for example, oxidative foot printing (Guan and 
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Chance, 2005) and Tandem Affinity Purification (TAP) (Gavin et al., 2002; Hyung and 
Ruotolo, 2012; Kaiser et al., 2008). Recently, the combination of a different fragmentation 
technique, Electron Transfer Dissociation (ETD) and a new generation commercial Q-IM-
TOF mass spectrometry was applied for  protein surface mapping (Lermyte et al., 2014).  
Those techniques definitely contribute to the understanding the composition, structure and 
dynamics of macromolecular assemblies. 
2.5 Integrative Modeling 
The development of the Integrative Structural Biology techniques goes hand in hand with the 
development of computational methods. Recently, several remarkable platforms were 
reported, such as the Integrative Modeling Platform package (IMP) 
(http://www.integrativemodeling.org/) which can deal with restraints from a variety of data 
including X-ray crystallography, EM, XLMS, IMMS, SAXS and proteomics to build up 
relevant models (Russel et al., 2012; Webb et al., 2011). The platform, for example, sheds 
light on the molecular architecture of 26S proteasome which provided further insights on the 
evolution and function of this enormous complex (Lasker et al., 2012). Another powerful 
macromolecular structure modeling software, Rosetta (https://www.rosettacommons.org/) 
was applied on the structure determination of bacterial type III secretion needle (Leaver-Fay 
et al., 2011; Loquet et al., 2012). The High Ambiguity Data-Driven Docking program 
(HADDOCK) (http://www.nmr.chem.uu.nl/haddock/) allows to directly apply docking onto 
generic multicomponent complexes (Karaca and Bonvin, 2013; de Vries et al., 2010).  In 
short, the combination of integrative structural biology experimentation and integrative 
computational modeling can result in detailed understanding of the phenomenon of 
macromolecular assemblies; further can lead to a mechanistic understanding of cell function 
and to cellular tomograms. 
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2.6 Conclusion and Perspectives 
In order to study the structure and function of individual proteins as well as their involvement 
in large multicomponent assemblies, Integrative Structural Biology is the most appropriate 
approach to generate data at different levels of resolution. The recent applications of IMMS 
enlighten   the   super   assembly   involved   with   β   barrel   membrane   protein   and   intrinsically 
disordered protein interactions and of XLMS successful apply on the in vivo whole cell 
samples (Housden et al., 2013; Weisbrod et al., 2013).  The development of instrumentation 
as well as of computational modeling tools in this field allows us to overcome challenges that 
exist in terms of sensitivity (analysis of protein complexes at physiologically relevant 
concentrations), coverage (e.g. membrane associated proteins) and speed, (transient 
interactions).  Many challenges are still lying on the way to understand the detailed function, 
evolution and modulation of cellular machineries. Definitely the Integrative Structural 
Biology will play an essential role in those studies, and MS as an independent or 
complementary approach will play a crucial role as a bridge to integrate and model different 
kinds of data on protein interactions.  
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3.1 Prologue: Structure and function of the HipA-HipB toxin-
antitoxin system in E.coli 
HipA is recognized for its crucial role in persistence and multidrug tolerance. It was firstly 
discovered by Harris Moyed during a target screening in the search of genes linked to a high 
frequency of persister cells in 1983 (Moyed and Bertrand, 1983). Compared to the wild type 
E.coli K-12, A 1000 times higher frequency of persister formation upon treatment of 
ampicillin was observed after mutation of the hip locus (hipA7 allele). This mutation reduces 
the lethality of selective inhibition of peptidoglycan synthesis and results in a severe growth 
defect at low temperature, hence persistence was linked to cold sensitivity (Scherrer and 
Moyed, 1988). Only until 2003, the hipA7 was sequenced and a double mutation, G22S and 
D291A, was revealed compared to the wild type hipA locus (Korch et al., 2003). Subsequent 
experiments indicated that the single mutation D291A was sufficient for the high persistence 
phenotype in E.coli and the ectopic induction of hipA could inhibit DNA replication, 
transcription and translation (Korch and Hill, 2006). Black et al. initially described that the 
hipA and the upstream neighbor gene hipB form an operon and Falla et al. firstly classified 
the hipA-hipB operon as a toxin antitoxin module. Indeed, hipA expression is toxic to the cell 
in the absence of HipB. HipB was further demonstrated to be a Cro-like DNA binding protein 
using a classical helix-turn-helix DNA binding motif and (Black et al., 1991, 1994; Falla and 
Chopra, 1998). HipA was further identified to have a eukaryotic serine/threonine kinase-like 
folding with closest similarity to the PI 3/4 kinase superfamily through sequence comparative 
analysis. HipA can be autophosphorylated at the residue Ser150 in the presence of ATP and 
Mg2+ in vitro. Mutation of the potential ATP and Mg2+-binding site residues D309 or D332 
revealed the importance of this phosphorylation in the HipA function since it resulted in the 
defect of cellular growth inhibition upon HipA overexpression (Correia et al., 2006).  
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A ground break understanding of the HipA-HipB molecular mechanism came from resolving  
the atomic crystal structure of E.coli ternary complex of HipA-HipB with its operator DNA 
sequence (Schumacher et al., 2009). HipB does not directly counteract the HipA toxin 
function by itself.  It rather acts by the formation of a heterotetramer HipA-HipB2-HipA 
sandwich complex where the HipA molecules use their N- and C-terminus to bind the 2 HipB 
molecules from the dimer respectively. This complex was thought to further bind with the 
palindromic operator DNA sequence of the hipA-hipB operon thus neutralizing the HipA 
toxicity by suppressing its expression (Schumacher et al., 2009). Recently, crosstalks 
between multiple toxin-antitoxin systems and also in the HipA-HipB module were denoted; 
the transcription repressor HipB was revealed not only to negatively regulate its own 
operators from the HipA-HipB module but it also binds to as many as 39 other putative 
palindromic sequences. For example, this results in the negative regulation of RelA 
expression (Kasari et al., 2013; Lin et al., 2013).  
The structural analysis of HipA further revealed its kinase activity. HipA binds with ATP and 
Mg2+ and autophosphorylates at Ser150. The structural data revealed that this 
autophosphorylation was through interaction of two HipA molecules and that it uses an 
unusual phosphorylation loop (pLoop) ejection mechanism (Schumacher et al., 2009, 2012). 
The phosphorylation of HipA could serve for the autoregulation mechanism and deactivates 
the HipA kinase activity (Schumacher et al., 2012). In the work of Schumacher et al, the 
essential elongation factor Tu (EFTu) was first reported as the target of HipA kinase; HipA 
would then inhibit macromolecular synthesis by interrupting the elongation process via 
phosphorylating EFTu (Schumacher et al., 2009). However, this could not be confirmed by 
other groups and most recently, EFTu was confirmed not to be the actual substrate of HipA. 
A genetic high throughput screening by overexpressing approximately 4120 genes in E.coli 
indicated that glutamyl tRNA synthetase (GltX) was the only gene of which overexpression  
HipA-HipB Structural Insights 
66 
neutralizes the toxicity of HipA (Germain et al., 2013a). The cold sensitivity phenotype of 
hipA7 was also reported to be suppressed by the overexpression of GltX (Kaspy et al., 2013a) 
and further experiments revealed that HipA can phosphorylate the GltX at the Ser239 which 
is near the active center and can inhibit aminoacylation (Germain et al., 2013a). The 
phosphorylation of GltX could result in the accumulation of uncharged tRNAGlu of which 
binding at the A site of the ribosome may lead to the activation of the stringent response. 
Indeed, synthesis of (p)ppGpp through the RelA mediated pathway was proposed to be the 
mechanism to generate the type I persistence (Bokinsky et al., 2013a; Germain et al., 2013b; 
Kaspy et al., 2013a).  
The threshold phenomenon of Toxin-antitoxin systems like HipA-HipB is believed to play a 
role in the co-existence of dormant (persisters) cells in a bacterial populations. It was 
indicated that in other toxin-antitoxin systems, mainly type II such as Doc-Phd or RelA-RelB, 
conditional cooperativity is essential to keep a storage pool of the toxin to generate the type I 
persistence (Cataudella et al., 2013; Gelens et al., 2013). Conditional cooperativity means 
that suppression of toxin production by binding of the toxin antitoxin complex to their 
operator will only occur when the toxins are in the proper stoichiometry compared to the 
antitoxins level. Conditional cooperativity was reported to stabilize the antitoxin level in 
rapid growing cells, preventing the random activation of toxin and promotes fast translational 
recovery (Cataudella et al., 2012). However, for the HipA-HipB module in the persister cell 
formation, conditional cooperativity was not demonstrated and the simple threshold models 
were still far from satisfactory because it ignores several aspects concerning the key HipA-
HipB autoregulation pathway such as the autophosphorylation of HipA and the reversion 
growth arrest phenomenon of phosphorylated HipA (Feng et al., 2014; Rotem et al., 2010). 
Hence, regarding the molecular mechanism of HipA-HipB as a regulator of persister 
formation, there are still far more questions to answer, such as:  what is role of HipA 
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autophosphorylation involved in the complex formation between HipA-HipB and its operator 
DNA, how the cell manages to keep a storage toxin HipA pool generate persister cells 
without conditional cooperativity like the other type II toxin antitoxin systems, or is there 
another mechanism of possible conditional cooperativity in the HipA-HipB module. 
 
3.2 Abstract 
Nearly all bacteria exhibit a type of phenotypic growth described as persistence that is 
thought to underlie antibiotic resistance, infection relapse, and recalcitrant chronic conditions. 
The chromosomally encoded high-persistence (Hip) antitoxin/toxin proteins HipB and HipA 
from Shewanella oneidensis, an opportunistic pathogen with unusual respiratory capacities, 
constitute a type II toxin-antitoxin protein couple. Here we show that phosphorylated HipA 
can engage in an unexpected ternary complex with HipB and double stranded operator DNA 
that is distinct from the prototypical counterpart complex from E.coli.  The structure of HipB 
in complex with operator DNA reveals a flexible C-terminus that is sequestered by HipA in 
the ternary complex, indicative of its role in binding HipA to abolish its function in 
persistence. The structure of a HipA mutant devoid of phosphorylation capacity in complex 
with a non-hydrolysable ATP analogue uncovers that HipA autophosphorylation is coupled 
to an unusual conformational collapse of its pLoop. However, HipA is unable to 
phosphorylate the translation factor Elongation factor Tu (EFTu), contrary to previous reports 
but in agreement with more recent findings. Our studies suggest that the phosphorylation 
state of HipA is an important factor in persistence and that the structural and mechanistic 
diversity of HipAB modules as regulatory factors in bacterial persistence is broader than 
previously thought. 
 
 
HipA-HipB Structural Insights 
68 
3.3 Introduction 
To cope with unpredictable environmental fluctuations bacteria resorted to population 
diversity as a risk-spreading strategy. By creating a phenotypic or genetically heterogeneous 
population bacteria essentially increase the probability that at least a subpopulation is well 
adapted to the actual environment (Acar et al., 2008; Avery, 2006; Hersh et al., 2004).  A 
striking example of such phenotypic diversity is the emergence of persister cells as a small 
subpopulation of cells able to survive against an antibiotic challenge by entering a dormant 
state with increased tolerance against a wide variety of stresses (Lewis, 2010). Recently, a 
tight correlation between multidrug tolerant (MDT) persister cells and biofilm formation has 
been shown, further the crucial role in investigation of persistence and biofilm formation can 
lead to the understanding of recalcitrant infection disease and antimicrobial drug discovery 
(Balaban et al., 2013; Lewis, 2013). While bacterial persistence was discovered almost 70 
years ago, its understanding at the molecular level is a relatively recent development and has 
coincided with the discovery of the hipA gene in Escherichia coli (Bigger, 1944; Moyed and 
Bertrand, 1983; Moyed and Broderick, 1986).  The product of hipA and its upstream linked 
gene hipB form a toxin antitoxin module, which together are recognized as a major factor 
involved in persistence (Black et al., 1994).  The toxin HipA is a kinase and its activity is 
essential for growth arrest and multidrug tolerance in E.coli K12 (Correia et al., 2006).  A 
first functional annotation of HipA by Schumacher et al. had linked HipA to phosphorylation 
of elongation factor Tu (EFTu) resulting in inhibition of protein biosynthesis. However, more 
recent studies have demonstrated that EFTu is not the phosphorylation target of HipA but 
glutamyl-tRNA synthetase (GltX) instead (Germain et al., 2013a).  Furthermore, HipA has 
been shown to trigger growth arrest by controlling RelA-mediated biosynthesis of the 
alarmone (p)ppGpp (Bokinsky et al., 2013b; Korch et al., 2003). The function of HipB has 
been much clearer in that it utilizes its DNA-binding capacity to bind to operators upstream 
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of the hipAB operon to neutralize HipA in the nucleolus, thereby serving as an antitoxin. 
Formation of a HipAB complex suppresses the transcription and translation of HipA 
(Schumacher et al., 2009, 2012). However, the detailed mechanism of growth arrest and 
growth arrest rescue has remained unclear to go along with lack of knowledge of how 
bacteria emerge from the dormancy and how they repopulate the growth phase.  
We previously demonstrated that interruption of the SO0706 gene involved in Shewanella 
oneidensis MR-1 resulted in a 50% decrease in biofilm formation (Theunissen et al., 2010)  
This gene encodes a protein sharing 28% sequence identity with E.coli HipA. S.oneidensis 
MR-1 is a respiratory diverse model bacterium that attracted interest for its role in 
biogeochemistry, its potential for bioremediation of heavy metals and aromatic compounds as 
well as for its use in microbial fuel cells (Gorby et al., 2006; Heidelberg et al., 2002). Many 
of these applications rely on the potential of the organism to form biofilms on inorganic 
surfaces. Molecular studies on the mechanisms of biofilm formation by this organism 
established a role for a type IV pilus system, the presence of extracellular DNA and the 
mxdABCD gene cluster, encoding a polysaccharide biogenesis system (Thormann et al., 
2004). A microarray analysis of the early stage of biofilm formation revealed the involvement 
of different metabolic processes and cyclic di-GMP dependent pathways which was recently 
confirmed by molecular characterization of PdeB, a c-di-GMP phosphodiesterase (Chao et 
al., 2013; Thormann et al., 2006) . The sequencing of the S.oneidensis MR-1 genome 
(Heidelberg et al., 2002) inspired efforts to gain insight into the regulatory and metabolic 
network and to get systematic level understanding of its capacities.  In general, research has 
mainly focused on the respiratory and redox potential of S.oneidensis and applications thereof 
in bioremediation and electromicrobiology. Although biofilm formation is an important 
aspect of the natural occurrence of S.oneidensis MR-1 and crucial for its biotechnological 
application, rather few efforts have been undertaken to understand the fundamentals of this 
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phenomenon in this organism. Given the strong correlation between biofilm formation and 
persistence, as well as the potential involvement of SO0706 in this process we further 
investigated the structure and function of this protein.  
Here, we report the results of a broad range of biochemical, molecular and structural biology 
experiments on the SO0705:SO0706 operon encoding a HipA-HipB related toxin-antitoxin 
module. We provide the atomic structure of the ternary HipABso protein complex with its 
double stranded operator DNA and of HipAso bound to an ATP analogue. Interestingly, in the 
HipABso:DNA crystal only the phosphorylated HipAso co-crystallized with HipBso and DNA 
form the ternary complex. The phosphorylation of HipAso, which uses an unusual pLoop 
conformation collapse from buried to exposed, is thought to be the trigger for growth arrest.  
However our direct observation of phosphorylated HipAso in a ternary complex indicates that 
HipBso could rescue growth arrest by directly targeting the active phosphorylated HipAso 
population.  Furthermore, C-terminus of HipBso undergoes dramatic conformational changes 
between the unbound form and when in complex with HipAso, indicating a role of the 
proteolysis regulation mechanism. Furthermore, we find that S.oneidensis MR-1 HipAso is 
neither able to bind to nor can phosphorylate EFTuso in agreement with recent findings for the 
E.coli counterpart.  
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3.4 Material and Methods 
3.4.1 Expression and purification of recombinant proteins and complexes 
thereof  
Expression constructs for S.oneidensis MR-1 HipAso (SO0706) and HipBso (SO0705) were 
established based on primers MR01, MR02 for HipAso and MR03, MR04 for HipB (Table 
S1), and were cloned into the pET15b expression vector (Merck Millipore). The D306Q 
mutant of HipAso was generated via overlapping PCR using the flanking primer MR01 and 
internal primer MR06 in one reaction and the flanking primer MR02 and internal primer 
MR05 in another reaction. The PCR products were gel purified and used in a final overlap 
PCR round using the flanking primers MR01 and MR02. An expression construct for 
S.oneidensis MR-1 EFTuso (SO0229) was PCR amplified with primer MR07, MR08 from 
S.oneidensis MR-1 genomic DNA (Table S1) and was cloned into a TOPO pCR2.1 vector 
(Invitrogen). S.oneidensis MR-1 HipAso and HipBso were expressed in E.coli BL21 DE3 and 
EFTuso in E.coli C43. Bacterial cultures were inducing for 1 h (HipAso) or 4h (HipBso and 
EFTuso) with 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG) (Duchefa Biochemie) and 
were grown to an OD600 of 0.6-0.7 in LB medium supplied with Carbenicillin (100µg/ml) at 
37ºC. The cells were harvested by centrifugation at 7000g for 10 min at 4°C. After 
resuspending the cell pellets in 25 mM Na2HPO4 pH 7.5, 500 mM NaCl buffer with EDTA 
free protease inhibitor, the cellular suspension was sonicated and the soluble fraction was 
clarified by centrifugation at 75000g for 30 min. The clarified lysate was loaded on Ni-NTA 
column (Qiagen) and pre-equilibrated with buffer A (25 mM Na2HPO4 pH 7.5, 500 mM 
NaCl, 10mM imidazole), washed with buffer B (25 mM Na2HPO4 pH 7.5, 500 mM NaCl, 
50mM imidazole) and eluted with gradient buffer C (25 mM Na2HPO4 pH 7.5, 500 mM 
NaCl, 500mM imidazole). The recombinant proteins were concentrated and subsequently 
further purified by size exclusion chromatography on a Prep-Grade Hiload 16/60 
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Superdex200 column (GE Healthcare) equilibrated with buffer (10mM HEPES, 300mM 
NaCl and 5% glycerol pH7.5). All procedures for the overexpression and purification of 
EFTuso protein are the same as for except that we added 0.2mM GDP and 5mM MgCl2 in the 
buffers used for purifications. The N-terminal 6xHis-tag in HipB was cleaved with 
biotinylated thrombin (Novagen) during overnight incubation and repurified with size 
exclusion chromatography. Pure fractions were pooled and proteins were concentrated for 
further experiments.  
To assemble the HipABso in complex with its operator DNA, purified HipAso and HipBso 
were mixed with double-stranded operator DNA obtained by annealing two single primers 5’-
ATTAGGTGTACTTATCTACACTTTTT-3’   and 5’-
AAAAAGTGTAGATAAGTACACCTAAT-3’   (IDT). The HipABso-DNA complex was 
purified by size exclusion chromatography. 
3.4.2 Crystallization and X-ray data collection of HipABso: DNA complex, 
HipAso-AMPPNP-Mg and HipBso 
All crystallization trial experiments were performed via the vapor diffusion method using a 
Mosquito robot (TTP LabTech). Crystals of HipAso in complex with Mg2+-AMPPNP grew in 
two days 20 qC by mixing 200 nL purified recombinant HipAso with 2mM AMPPNP (Sigma) 
and 10mM MgCl2 with an equal volume of reservoir solution (0.2M sodium chloride, 0.1M 
Na HEPES pH7.0, 25% Polyethylene glycol 4000) were equilibrated against 200 nL reservoir 
solution. For X-ray data collection under cryogenic conditions the crystals were harvested 
from the drop and frozen in a cryostream using crystallization condition supplemented with 
20% glycerol as cryoprotection solvent. Crystals of the HipAso-AMPPNP complex belonged 
to spacegroup P212121 with a=60.70 Å, b=75.83 Å, c=110.32 Å and α=β=γ=90° and 
diffracted to 1.83 Å resolution. Crystals of recombinant HipBso were grown overnight from 
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purified HipBso after cleavage of the N-terminal 6xHis-tag. From 0.1M Na HEPES pH7.5, 
10% v/v 2-propanol, 20% PEG 4000 and diffracted to 1.85 Å. The crystals belonged to space 
group C2221 with a=53.46Å, b=72.95Å, c=86.91Å and α=β=γ=90°. 
Crystals of recombinant HipABso in complex with its operator DNA complex were grown in 
the crystallization geometries described above from reservoirs containing 0.2M calcium 
acetate hydrate pH7.5, 20% Polyethylene glycol 3350. For cryoprotection, the HipABso: 
DNA crystals were first incubated for several minutes in the crystallization condition 
supplemented with 20% glycerol. We identified two crystal forms that diffracted to 3.39 Å 
and 3.79 Å respectively. The first crystal form diffracted to 3.39Å belonged to spacegroup 
P212121 with a=57.82 Å, b=122.45 Å, c=189.85 Å and α=β=γ= 90°. The second crystal form 
in spacegroup P21 with a= 72.24 Å, b= 57.33 Å, c= 171.38 Å and α=γ= 90°, β= 95.8° 
diffracted to 3.79 Å resolution.  All X-ray diffraction data were processed with XDS and the 
XIA2 routine (Kabsch, 2010; Winter, 2010). 
3.4.3 Crystal structure determination of HipAso-AMPPNP-Mg2+, HipBso 
and HipABso: DNA 
The structure of HipAso-AMPPNP-Mg2+ was determined via the molecular replacement 
platform BALBES (Long et al., 2008), using the S.oneidensis MR-1 HipAso sequence and the 
crystal structure of E.coli HipA (PDB: 3DNU) structure as input. The structure was refined 
extended to completion using Phenix.AutoMR, Phenix. Refine and Phenix.AutoBuild 
(Adams et al., 2010). The final HipA-AMPPNP structure contains one molecule of HipA per 
asymmetric unit cell including the all 433 residues from HipA and 5 residues from the 
affinity purification tag, 1 AMPPNP molecular, 2 Mg2+ ions, 1 Na+ ion, and 486 water 
molecules. The structure has excellent geometry which was indicated by the Ramachandran 
analysis in the X-ray data collection and refinement statistics table. 
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To determine the structure of HipBso, the S.oneidensis MR-1 HipBso sequence and a subunit 
from the crystal structure of dimeric E.coli HipB (PDB: 3DNV) were used to create a 
truncated search model lacking loop regions and non-conserved side-chains using CCP4 
Chainsaw. The structure was determined using molecular replacement protocols implemented 
in MOLREP and Phenix.Phaser  and was refined using Phenix.Refine (Adams et al., 2010; 
Vagin and Teplyakov, 1997). The final HipBso structure, which contains 1 dimer HipBso in 
the crystal asymmetric unit including residues 24-87 for one subunit and residues 17-87 for 
the second subunit, 123 water molecules in the dataset of 1.85 Å resolution and including 
residues 17-87 for both subunits, 39 water molecules in the dataset of 2.35 Å resolution. 
The HipABso:DNA complex structure was determined by molecular replacement protocols 
implemented in Phenix.AutoMR using the HipA-AMPPNP monomer and the HipBso dimer 
as search models. The limited diffraction of crystal forms 1 and 2 for the HipABso:DNA 
complex necessitated the use of weak data at the diffraction limit of the crystals as indicated 
by half-data set Pearson correlation coefficient (CC1/2) (Karplus and Diederichs, 2012), and 
the quality of the resultant electron-density difference maps. Both the orthorhombic and 
monoclinic crystals contain 2 monomers of HipAso, 1 dimer of HipBso and double stranded 
DNA in the asymmetric unit cell. After initial rounds of refinement, clear electron density 
could be observed for the DNA duplex  which allowed modeling of the complete DNA 
sequence in COOT (Emsley and Cowtan, 2004). The final HipABso: DNA structure contains 
2 HipAso which were found to be the phosphorylated form, with remodeling of the 
phosphorylation loop including residues 7-433, 1 dimer HipBso including residues 20-87, 1 
double stranded DNA with 24 and 25 nucleotides in each strand. 
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3.4.4 Nano Liquid Chromatography Mass Spectrometry  
Freshly purified HipAso in 10mM ATP 20mM MgCl2 and HipAso treated with lambda 
phosphatase overnight were diluted 1:50 with 50mM ammonium bicarbonate buffer. 
Sequencing-grade trypsin (Sigma) was added in 1:50 ratio to the diluted protein and digested 
overnight at 37 degrees. 1pmol HipA digestion sample from those 3 groups was applied for  
LCMS analysis on a nanoACQUITY UPLC coupled to a Synapt mass spectrometer used in 
the Q-TOF mode (Waters). A nanoACQUITY UPLC@2G-V/M Trap column 108µm*20mm 
5µ symmetry C18 (Waters) was used as the trap column at 15 µL/min for 1min. A 
nanoACQUITY UPLC 1.8µm HSS T3 75µm*250mm column (Waters) was used as the 
separation column at 0.25 µL/min with a gradient as follows: 3%B to 40%B 0-30min, 40%B 
to 85%B 30-31min, 85%B 31-35 min, 85%B-3%B 35-35.5min, 3%B until 65min using 0.1 
formic acid as buffer A and 100% Acetonitrile as buffer B. All the Nano LCMS data were 
processed with the PLGS 2.5 software (Waters).  
3.4.5 Isothermal Titration Calorimetry 
Experiments were carried out on a VP-ITC MicroCalorimeter at 25 degrees and data were 
analyzed using the origin ITC analysis software package (MicroCal). Purified HipA, HipB 
and DNA were matched into the buffer containing 25mM Na2HPO4, 300mM NaCl and 5% 
glycerol at pH7.5. The concentrations of HipAso, HipBso and DNA were measured by a 
Nanodrop spectrophotometer using an extinction coefficient generated from ProtParam 
(Uniprot Knowledgebase). All samples were degassed before the experiments. An initial 
injection of 2ul was followed by 10ul injection with 250s or 350s apart. The raw data were 
corrected and fitted to the one binding site model, and apparent molar reaction enthalpy (ΔH), 
apparent entropy (ΔS), dissociation constant (KD) and stoichiometry of binding (N) were 
generated. 
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3.4.6 Small Angle X-ray Scattering  
Small angle X-ray Scattering (SAXS) measurements of HipBso, HipBsoDNA, HipABso, and 
HipABsoDNA were carried out at Beamline SWING in SOLEIL (SOLEIL, Paris, France) 
with online HPLC separation (Shodex) in 25mM HEPES, 300mM NaCl and 5% glycerol 
pH7.5 buffer.  Buffer subtraction and extrapolation were performed with the program 
FOXTROT or PRIMUS. The Guinier region was evaluated by PRIMUS using the Guinier 
approximation. The Porod volume was evaluated using PRIMUS, the radius of gyration Rg, 
forward scattering I0, maximum particle dimension Dmax and the distance distribution 
function P(r) were evaluated using GNOM. Theoretical scattering patterns from available 
structures and generated models, together with their respective discrepancy to the 
experimental data, were calculated using CRYSOL from ATSAS package(Petoukhov et al., 
2012; Svergun et al., 1995). The molecular weight estimation was generated with the protocol 
described before (Rambo and Tainer, 2013). 
3.4.7 Bacterial growth experiments  
To construct the HipAB low copy expression vector, HipABso with native promoter region 
was PCR purified from genomic DNA of S.oneidensis MR-1 with the primers MR13 and 
MR14 (Table S1). The obtained PCR product was gel-purified and subcloned into the TOPO 
pCR2.1 vector (Invitrogen) prior digestion to ApaLI and XhoI. The digested fragment was 
cloned into the ApaLI and XhoI digested pACYCDuet expression vector (Merck Millipore), 
thereby producing the pACYCDuet-HipABso vector. To obtain the overexpression vectors, 
The HipAso, HipBso, HipABso gene were amplified from the S.oneidensis MR-1 with the 
following primers: MR9 and MR12 for HipAso; MR10 and MR11 for HipBso and MR10, 
MR12 for HipABso (Table S1). The obtained PCR products were gel purified and cloned into 
pBAD202/D-TOPO   vector   (Invitrogen)   following   the   manufacturer’s   instructions. 
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Subsequently the thioredoxin sequence was removed by digestion with NcoI, gel purification 
and relegation, producing respectively the pBADHipAso, pBADHipBso, pBADHipABso 
vectors. Plasmid DNA was introduced into S.oneidensis MR-1 cells by electroporation using 
a 2.5kV pulse. After electroporation cells were immediately suspended in 0.5mL LB, 
incubated at 28 degrees for 1 hour and plated on the LB agar with appropriate antibiotics. 
Bacteria were routinely grown on Lysogeny Broth (LB) agar plates or shaking  (200  rpm)  in  
LB  medium   at   28  ̊C for S.oneidensis strains. When appropriate, media were supplemented 
with antibiotics in the following concentrations: carbenicillin (Cb) 100μg/mL, 
chloramphenicol (Cm) 25μg/mL, kanamycin (Km) 25μg/mL. For the growth curves 
overnight grown precultures were diluted 1:20 to 1:30 to an optical density at 600 nm 
(OD600) of ~0.3. Aerobic growth was monitored directly, without the need to transfer culture 
samples into regular cuvettes, using a Shimadzu 1240 Mini Single-Beam UV-Vis 
spectrophotometer. Each growth curve was derived from three independent experiments for 
which the mean (+-SEM) is plotted. 
3.4.8 Radioactive kinase assay  
A standard radioactive kinase assay was performed in 11μl of reaction buffer (25mM HEPES 
pH 7.5, 150 mM NaCl, 25 mM β-glycerophosphate, 1 mM Na3VO4, 100μM ATP, and 100 
μM MgCl2) in the presence of 10μCi of [γ-32P] ATP and the purified HipA and EF-Tu. The 
reaction was allowed to incubate for 15 min at room temperature and quenched by the 
addition of 1/5 volume of SDS-PAGE loading buffer. The 32P labeled proteins were separated 
by SDS-PAGE, followed by autoradiography of the gels. As a negative control a reaction 
without 32P and a reaction with BSA were included. 
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3.5 Results 
3.5.1 HipAso and HipBso constitute a toxin-antitoxin module targeting an 
atypical operator DNA 
Transposon mutagenesis of SO0706 led to a strong reduction of biofilm formation in 
S.oneidensis MR-1 (Theunissen et al., 2010).  Sequence analysis revealed that the protein 
product of SO0706 (HipAso) shows clear homology to E.coli HipA with 28% identity (Figure 
S1).  The protein product of the adjacent gene, SO0705 (HipBso) is annotated as a toxin-
antitoxin antidote transcriptional repressor (Heidelberg et al., 2002). Despite significant 
similarities between the S. oneidensis and E. coli sequences, there are also striking 
differences in the operon structure which may reflect the functional diversity of such toxin-
antitoxin systems. For instance, the SO0705 and SO0706 genes are separated by 3 bp instead 
of overlapping by 1 bp as seen in the hipAB operon structure in E.coli. Furthermore, a 
palindromic operator sequence, GTGTA(N)6TACAC (N indicates random nucleotide), is 
repeated four times upstream of the hipABso gene. We note that the random nucleotide 
sequence within the operator is 2 bp shorter than in the E.coli HipAB system.  Interestingly, 
the 4th operator is inside of the HipBso open reading frame and the distance between the 
neighbor operon is also much larger than in E.coli (Figure S2a).  
To investigate the function of HipAso and HipBso we used S.oneidensis MR-1 cDNA to 
isolate the genes for HipBso, HipAso, HipABso and its operators DNA. By employing PCR 
primer pairs designed to span the entire region of HipBso and HipAso we were able to show 
that the two genes are transcriptionally coupled (Figure S2b). Complementation and 
overexpression mutants were created to study the HipABso physiological function and its role 
in persistence. We constructed pBAD series of vectors which were previously shown to allow 
a well-controlled expression system to study the toxic effects of HipAso (Korch et al., 2003). 
HipA-HipB Structural Insights 
79 
We observed that overexpression of HipAso using a pBAD vector in S.oneidensis MR-1 
causes a temporary inhibition of growth in both the wild type and the ΔHipBAso strain 
(Figure S2c). However, when HipAso was overexpressed in the ΔHipBso strain growth 
inhibition was acute as previously reported in E.coli (Black et al., 1991). This strongly 
suggests that mild overexpression of HipAso only causes a temporary inhibition but not 
termination of growth (Korch and Hill, 2006).  
To enable studies towards obtaining structural and mechanistic insights into the role of 
HipAso and HipBso in persistence, we overexpressed and purified recombinant HipAso and 
HipBso. Elution profiles during size exclusion chromatography (SEC), showed that HipAso 
eluted with as a 50 kDa monomer while HipBso purified as a dimer with an apparent 
molecular mass of 30kDa. Simple mixing of the proteins resulted in the formation of a 
complex between HipAso and HipBso with an apparent molecular mass of 130 kDa, consistent 
with a 2:2 stoichiometry. Furthermore, this complex can bind the single operator DNA 
sequence forming a homogeneous population (Figure 1a). In addition, estimation of the 
molecular weight estimation from Small Angle X-ray scattering experiments correlated well 
with the retention volumes in SEC (Table S2).  
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Figure 1: Biochemical reconstitution and characterization of HipBso (SO0705) and 
HipAso (SO0706) complexes (a) SEC profiles of HipBso (Orange), HipAso (Blue), HipAso-
HipBso complex (Red) and HipAso-HipBso: DNA complex (Green). SDS-PAGE analysis of 
peak fraction is accompanied with the SEC profile. (b) Thermodynamic characterization of 
the interaction between HipAso and HipBso (c) Thermodynamic characterization of the 
interaction between HipBso and single DNA operator (d) Thermodynamic characterization 
between HipBso:DNA complex and non-phosphorylated mutant HipAsoD306Q. The 
interaction  stoichiometry  and  affinities  are  shown  together  with  ΔH,  -ΔTS  and  ΔG. 
HipA-HipB Structural Insights 
81 
We used Isothermal Titration Calorimetry (ITC) to characterize the interaction between 
HipAso and HipBso, HipBso and its operator DNA, and the recruitment of HipAso to the 
HipBso:DNA complex (Figure 1b-1d). These experiments demonstrated that 2 monomers of 
HipAso bind 1 dimer HipBso with an equilibrium dissociation constant (KD) of 490nM and via 
an enthalpically-driven binding event (Figure 1b). On the other hand, the interaction of 
HipBso with operator DNA (26 bp) is endothermic, resulting in an entropically-driven binding 
event to establish a high-affinity interaction (KD = 290nM) (Figure 1c). Titration of double 
operator DNA (76bp) with HipBso revealed a similar affinity and thermodynamic fingerprint 
indicating that there is no cooperativity between the neighbor operators of HipBso binding 
(Table S2 and FigureS3c). Finally, we characterized the recruitment of HipAso to a 
HipBso:DNA complex. For this study we employed preformed HipBso:DNA complex and 
HipAso carrying a D306Q mutation and found that HipAso can bind to the HipBso: DNA 
complex with a KD of 300 nM and a thermodynamic binding profile that is very similar to the 
HipA:HipB interaction in the absence of DNA (Figure 1d) (Table S1).  
3.5.2 HipAso, HipBso and operator DNA assemble into a distinct ternary 
complex 
To dissect the structural basis of the assembly of the HipABso:DNA ternary complex we 
crystallized the complex in two different crystal forms and determined  crystal structures to 
3.39 Å and 3.79 Å resolution (Table 1). The S.oneidensis MR-1 HipABso:DNA ternary 
complex assembles as a compact HipBso dimer bound by a 25 bp duplex operator DNA, with 
each of the HipBso subunits interacting with a different HipAso subunit (Figure 2a). The 
HipABso:DNA ternary assembly bears striking differences compared to the previously 
characterized E.coli sandwich HipABso:DNA ternary complex (PDB:3DNV).  
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Figure 2: Structural studies of the HipAso-HipBso: DNA complex (a) X-ray crystal 
structure of HipAso-HipBso: DNA complex, HipBso dimer (Yellow) interacts with 2 HipAso C 
terminus helix bundles (Blue), the HipAso N terminus (Skyblue) has no interaction with 
HipBso. The other 90 degrees rotation views are shown with dimension parameters. (b) 
S.oneidensis MR-1 HipAso-HipBso: DNA assembles in a distinct way compared to the E.coli 
HipAB: DNA (PDB: 3DNV). The E.coli HipAB: DNA structure is shown in the same DNA 
top view as the left panel in Figure 2a. Instead, in the E.coli HipAB: DNA both C and N 
terminus of HipA interact with both of the HipB dimer molecules while in S.oneidensis MR-1 
HipABso: DNA assembly only the HipAso C terminus interacts with single HipBso molecules. 
(c) The SAXS data seal the distinct assembly, showing a fit of S.oneidensis MR-1 HipAso-
HipBso:  DNA  to  its  solution  structure  with  χ2=1.5 while the fit of E.coli HipA-HipB: DNA is 
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with   χ2=5.7. (d) The interaction interface between the HipAso and HipBso are shown with 
involved residues labeled. (e) The interaction interface between HipBso and DNA are shown, 
the four residues R380, R383, R384 and R429 from HipAso form a positive patch with DNA 
(f) Interaction between HipBso and DNA resulted in 125 degrees of bending of the normally 
linear DNA. HipBso mainly  uses   its  α2,  α3   and  α4  helix   turn  helix  motif   to   tightly   interact  
with DNA, and detail interactions are plotted with NUCPLOT in Figure S3a. The density of 
DNA is shown in 2Fo-Fc   contoured   at   1σ.   (g) Both copies of HipAso in the two ternary 
complexes are phosphorylated at Ser147. This phosphorylated residue is anchored through 
anion π interaction with HipAso F338 and hydrogen bond is formed between R145 and F338 
or E339. The density of pSer147 is shown in 2Fo-Fc=1σ   
 
 
Instead of binding a single HipAso C terminus helix bundle at each side of the dimer HipBso 
molecules, in E.coli the HipA uses its C and N terminus to bind with both the dimer HipB 
molecules simultaneous. Viewed from the top of the DNA double helix, there is a 90 degrees 
rotation of the HipAso out of the sandwich core plate (Figure 2b).  The S.oneidensis MR-1 
HipABso:DNA assembly was confirmed to be similar in solution and in crystal by a Small 
Angle X-ray  scattering  experiment  with  χ2=1.5  which  sealed  the  distinct  assembly  of  E.coli 
with  a  fit  χ2=5.7  (Figure 2c). The HipA:HipB binding interface is mainly hydrophobic with a 
buried surface of 470Å2 and features interactions between the C terminal helical-bundle 
domain of HipA and a hydrophobic patch on each HipB subunit (Figure 2d). In addition to 
the anticipated extensive interactions of HipB with DNA, HipA also makes specific 
interactions with the phosphodiester flank of the DNA duplex via a positively charged patch 
defined by  R380, R383 and R384 and R429 with an interface around 150 Å2 determined by 
PDB PISA server (Krissinel and Henrick, 2007) (Figure 2e). HipBso interacts tightly with its 
operator DNA using mainly its α2, α3 and part of α4, forming the expected helix-turn-helix 
DNA binding motif (Figure 2f and Figure S3a). Interestingly, binding of duplex DNA to the 
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HipABso complex causes the DNA to bend by about 125 degrees compared to linear DNA. 
HipBso bends the operator DNA more extensively that E.coli HipB does (125 degrees vs 110 
degrees). The latter can be explained by the fact that the distance between each operators’ 
binding site is shorter. 
The HipAso-HipBso-DNA complex is characterized by two unexpected features. In the first 
instance, HipA is phosphorylated at Ser147 (Figure 2g). The phosphate group of pSer147 is 
observed at full occupancy in both crystal forms of the HipAso-HipBso-DNA complex and is 
anchored by an anion-π interaction with F338. This binding mode is further stabilized by a 
hydrogen bonds between main-chain atoms of R145 and F338, and a salt-bridge between 
E339 (Figure 2g).  
3.5.3 The flexible C-terminal tail of HipBso is essential for targeting the 
HipAso hydrophobic pocket to prevent proteolysis 
An additional striking difference between E.coli and S.oneidensis HipAB:DNA complexes 
concerns the structural order of the C-terminus of HipB. We posit that this could have 
functional implications in terms of the post-translational regulation. In E.coli, the C-terminus 
of HipB is unstructured, even in the HipAB:DNA complex and it  has been demonstrated that 
the C-terminal tryptophan is proteolytically cleaved by the ATP-dependent Lon protease 
(Hansen et al., 2012). Interestingly, in our structure of the HipABso:DNA to 3.79Å resolution, 
we can trace the C terminus of HipBso into a hydrophobic pocket of HipAso. Moreover, in our 
second structure of HipABso:DNA to 3.39Å resolution, we see clear density in the same 
pocket for the last three C terminal residues GWY of HipBso (Figure 3a and Figure S3b). 
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Figure 3: The flexible C-terminal tail of HipBso is accommodated by a hydrophobic 
pocket in HipAso (a) The HipBso interacts with the hydrophobic core between HipAso N and 
C terminus by forming an R232HipA-W96HipB-R236HipA-F315HipA cation π interaction and one 
hydrogen bond with R235. The interaction between HipBso C terminus GWY with HipAso is 
plotted by Ligplot in Figure S3b.  (b) Although with only 18% of identity, the secondary 
structures of S.oneidensis MR-1 and E.coli HipB are highly conserved and the disordered C 
terminus W residue involved in targeting the HipA hydrophobic core is present in both. (c) 
The difference in structure of HipBso N termini is observed in the 2.35 resolution crystal 
form. The N termini from the dimer HipBso form  a  α0’  helix  and  β0  sheet   respectively.   (d)  
SAXS modeling indicated that both HipBso and HipBso: DNA complex have a disordered N- 
and C-terminus, which indicates that the binding of HipBso to HipAso is essential to keep the 
structure of the HipBso C-terminus ordered. 
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As it is widely accepted that the protease-sensitivity of the antitoxins is a mechanism for the 
regulation of toxin activity (Brzozowska and Zielenkiewicz, 2013; Donegan et al., 2010; 
Hansen et al., 2012), we pursued structural studies of HipB outside the context of the ternary 
complex with HipA and DNA to obtain insights into the plasticity and structural order of the 
C-terminus in HipBso.. We crystallized the HipB alone and solved the structure to 1.85Å and 
2.35Å resolution (Table 1). The crystal structures revealed that both the N- and C-terminal 
segments in HipBso are flexible. Moreover, a structure-based sequence alignment reveals a 16 
residues disordered extension in HipBso of which the function is yet unknown (Pei et al., 
2008) (Figure 3b). Interestingly, in our structure of HipBso to 2.35 Å resolution, the N 
termini of the two HipBso monomers adopt two different secondary structures, namely a β0 
strand and α0’   helix   respectively.   We also constructed the truncated form lacking the 16 
residues N-terminal extension and proved there was no interference of this disordered N 
terminus on the HipAso and HipBso binding by ITC experiment (Figure S3c). The C-terminus 
of HipBso alone is also flexible as no density can be observed in both of the high resolution 
crystal datasets (Figure 3c). Furthermore, SAXS experiments indicated that both in HipBso 
alone and in HipBso bound with operator DNA, the C terminus of HipBso is disordered 
(Figure 3d). Thus, the C terminus of HipBso is flexible and becomes ordered in the 
HipABso:DNA complex. 
3.5.4 HipAso is conformationally regulated by autophosphorylation 
In E.coli, HipA kinase activity is essential for growth arrest and multidrug tolerance (Correia 
et al., 2006). To further investigate the mechanism of HipAso in S. oneidensis MR-1, we 
solved the structure of HipAso in complex with the non-hydrolyzable ATP analogue 
AMPPNP to 1.83Å resolution (Table 1).  
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Figure 4: S.oneidensis MR-1 HipAso is regulated conformationally upon 
autophosphorylation (a)  5 loops in the HipAso structure are involved in the binding of 
AMPPNP and 2 Mg2+ ions, the residues involved in the Mg-AMPPMP binding are shown in 
stick and labeled in blue. The two Mg2+ ions are shown in green spheres. Detailed interaction 
between HipAso and AMPPNP, Mg2+ are plotted by Ligplot in Figure S4a. (b) Detailed view 
of the pLoop ejection after phosphorylation of HipAso.Ser147 from AMPPNP binding HipAso 
and pSer147 from pHipAso are shown in sphere with colored in C yellow, N blue, O red, P 
Orange. (c) The sequence alignment between S.oneidensis MR-1 and E.coli is accompanied 
with nanoLCMS identification of the phosphorylated peptide, the peptide LSVAGVQPK was 
observed at charge 2+ state in two forms differing 80Da in molecular weight. 
HipA-HipB Structural Insights 
89 
This structural analysis at high resolution revealed binding of AMPPNP and Mg2+ at high 
occupancy and delineation of the full interaction landscape (Figure 4a and Figure S4a). The 
ATP binding site in HipAso is engulfed by the N- and C-terminal domains and most 
interacting residues are contributed by five loop regions (Figure S4b). All residues involved 
in Mg2+ and ATP binding are highly conserved in S.oneidensis MR-1 and E.coli (Figure 4a) 
(Figure S1). We propose that phosphorylation of HipAso is essential for the formation of the 
ternary HipABso:DNA complex.  This could be a common feature for the HipA kinase 
family. The HipAso pLoop consists of residues 129-152 and is ejected out of the pocket 
compared to the non-phosphorylated form (Figure 4b). Furthermore, the pLoop in 
autophosphorylated HipAso as observed in the HipABso:DNA complex, projects to the 
surface. Such activation mechanism involving ejection of the pLoop upon phosphorylation 
has also been  proposed for in E.coli HipA (Schumacher et al., 2012). To investigate the 
autophosphorylation capacity of HipASO, we incubated freshly purified HipA with ATP and 
Mg2+ overnight and observed a dramatic increase of the corresponding phosphorylated 
peptide intensity from approximately 8% to almost 50% relative to the signal of the non-
phosphorylated peptide in LC-MS (Fig. 4c).   
In E.coli, HipAso is autophosphorylated at Ser150. Similarly, our structural analysis revealed 
that in S.oneidensis MR-1, HipA can autophosphorylate at Ser147 which aligns with Ser150 
in E.coli HipA. We note that both of our crystal forms of the HipABso:DNA complex contain 
phosphorylated HipA in sharp contrast to the E.coli HipAB complex (Evdokimov et al., 
2009; Schumacher et al., 2012). Upon superposition of the N-terminal domains of 
phosphorylated and unphosphorylated HipAso (derived from the AMPPNP complex) we 
observed a rigid-body shift of the HipAso C-terminal domain by about 2 Å shifts (Figure 
4Sc). Given that this part of HipAso interacts with DNA in the ternary complex with HipBso, 
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we propose that the phosphorylated form of HipAso may be important in the complex 
assembly and stability. 
3.5.5 Functional investigation of S.oneidensis MR-1 HipAso (SO0706) 
HipA was the first toxin protein that was linked to the phenomenon of persistence and, its 
overexpression in E.coli resulted in multiple effects including growth arrest, inhibition of 
macromolecular synthesis as well as DNA replication and transcription (Correia et al., 2006; 
Korch and Hill, 2006; Korch et al., 2003; Pei et al., 2008). EFTu was originally identified as 
the substrate of the kinase activity of HipA in E.coli, thereby creating a functional link 
between HipA and the inhibition of translation (Schumacher et al., 2009). However, repeated 
attempts to show that HipAso has an analogous activity failed, leading to the conclusion that 
EFTuso does most likely not constitute a substrate for HipAso (Figure S5a). Furthermore, ITC 
and pull-down experiments revealed the absence of interaction between these proteins 
thereby corroborating the functional assay (Figure S5b). 
 
3.6 Discussion 
We here provided structural insights into the toxin antitoxin system HipA-HipB and its 
operator DNA assembly in S.oneidensis MR-1, which can now serve as a second example of 
such complexes next to the previously characterized E.coli HipAB:DNA complex. The 
S.oneidensis MR-1 HipABso:DNA assembly is sharply distinct from the described E.coli 
assembly, providing new insights into the structural and mechanistic diversity of HipAB 
modules and cautioning against the use of a single model organism for deriving functional 
generalizations. In E.coli the phosphorylation of HipA evokes pLoop ejection and is thought 
to release HipA from HipB in the HipAB:DNA complex (Schumacher et al., 2012). However, 
we have now provided direct structural evidence that phosphorylated HipA can participate in 
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the HipABso:DNA complex form, and further that the phosphorylation site is blocked and 
anchored through anion-π interaction. This suggests that HipB may play an active role in 
recruiting activated HipA to avoid growth arrest. We also observed that upon release of HipA, 
the HipB structure is destabilized, probably making it more prone to proteolytic degradation. 
This could help to propagate the effect of HipA-regulated persistence. This raises a new 
question about the possible molecular trigger for the release of HipA from HipB given that p-
loop ejection does not appear to do so.  
We further provide information that EFTu is unlikely to be the substrate of toxin HipA in the 
case of S.oneidensis, which is in agreement with more recent findings. While it was originally 
believed that it HipA halted ribosomal activity by phosphorylating EFTu (Schumacher et al., 
2009, 2012), it was recently established that its natural substrate is actually glutamyl-tRNA-
synthetase. By phosporylating this enzyme at its ATP binding site, uncharged tRNAGlu 
accumulates and the stringent response is activated (Germain et al., 2013a; Kaspy et al., 
2013b). Mining the S.oneidensis MR-1 genome database and the Toxin-Antitoxin database 
(TADB) revealed that multiple homologues of the HipAB toxin antitoxin system exist in 
S.oneidensis MR-1 (Shao et al., 2011). Besides SO0705 (HipBso), SO0706 (HipAso); SO3169, 
SO3170 and SO0062, SO0063 are also annotated as members of the HipAB toxin antitoxin 
system. Interestingly, despite the low identity (15-20%) between the predicted HipA-like 
proteins SO3170, SO0063 and SO0706,  the residues involved in Mg2+-ATP binding and Ser 
phosphorylation are highly conserved (Figure S6). Moreover, upstream of those predicted 
HipA like proteins, there is also one helix-turn-helix DNA binding HipB-like protein and a 
potential operator. Thus, it appears that there might be functional redundancy of such proteins 
in S.oneidensis which may complicate future studies in delineating the exact role of HipA 
activity in this organism.  
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Figure S1. Sequence alignment of S.oneidensis MR-1 and E.coli K12 HipA which indicates a 
28% identity, the orange underlined highlighted sequences show the 5 loops involved in 
AMPPNP and Mg2+ binding. 
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Figure S2. a. Comparison of operator sequences in S. oneidensis MR-1 and E. coli HipAB 
system. The 4 operator sequences were underlined and conserved sequence were in bold. The 
red highlight indicates the start codon of HipB. b. Operon organization of HipABso from S. 
oneidensis MR-1. Agarose gels are stained with ethidium bromide. (A) S. oneidensis total 
cDNA template and primers ES31 and ES32. (B) S. oneidensis total cDNA template and 
primers ES46 and ES47. (C) S. oneidensis total cDNA template and primers ES48 and ES49. 
(Neg. Ctrl. =negative control, using no-RT RNA template to asses DNA contamination in 
RNA preparations; Pos.Ctrl. = positive control, using S. oneidensis genomic DNA template). 
c. Growth experiments indicated overexpression of HipAso results in temporary inhibition of 
growth in S.oneidensis MR-1.  Left panel: overexpression of HipAso, HipBso and HipABso 
in the wild type S.oneidensis MR-1; right panel: overexpression of HipBso, HipABso in the 
ΔHipAB  mutant  S.oneidensis MR-1. At least three independent bacteria growth of each strain 
were evaluated for each experiments, error bars indicate the standard error of mean. 
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Figure S3.a. Protein:DNA interaction sites in the ternary HipAso-HipBso:DNA  complex 
plotted by NUCPLOT. b. The Two HipBso monomers C terminus GWY interaction with 
HipAso molecules plotted by Ligplot. Red circles indicate the hydrophobic interaction from 
HipAso. c. ITC experiments of HipB with 2 operator DNA (76bp) and Nt truncated HipB with 
HipA 
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Figure S4. a. Details of the interaction between HipAso, AMPPNP, Mg2+ and water 
molecules plotted by Ligplot. The blue balls represent the water molecules involved in the 
interaction. b. Density map of AMPPNP in the HipAso-AMPPNP-Mg structure showed in 
2Fo-Fc=2σ level, the surface view of theHipAso-AMPPNP-Mg structure represents a pocket 
for the ATP binding. c. Alignment of the HipAso AMPPNP Mg bound form and 
phosphorylated HipA form showed that the phosphorylation loop is ejected from inside to 
outside. The pLoop is shown in orange with phosphorylation site is shown in atom colored 
sphere. The alignment of the N terminus also resulted in a 2Å shift of the C terminus helix 
bundle which is essential for the DNA binding. pHipA in blue, AMPPNP Mg binding HipA 
in grey. 
 
  
HipA-HipB Structural Insights 
104 
 
Figure S5. a. Radioactive kinase assay indicated there is no phosphate transfer between 
S.oneidensis MR-1 HipAso and EFTuso. HipAso was used as positive control and 
HipAsoD306Q was used as negative control in this experiment. 1 HipAsoD306Q, 2 HipAso, 3 
HipAso+EFTuso-His, 4 HipAso+EFTuso-GST, 5 HipAso+EFTuso-His+GDP, 6 HipAso+EFTuso-
GST+GDP, 7 HipAsoD306Q+EFTuso-His+GDP 8 HipAsoD306Q+EFTuso-GST+GDP. SDS 
PAGE analysis 9 EFTuso-His, 10 HipAso, 11 EFTuso-GST. b. ITC experiment reveals that 
there is no interaction between HipAso and EFTuso. 
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Figure S6. Sequence alignment of SO0706 (HipAso); SO3170 and SO0063, the green stars 
represent the potential Ser phosphorylation site and the red star represent the ATP and Mg2+ 
binding site, those residues are high conserved between those 3 predicted HipA family 
proteins . 
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Table S1. Primers that used in this study. 
 
Name Sequence(5’-3’) 
MR01 CATATGAGTACAGCTAAAACGCTTACG 
MR02 GGATCCCTACACTTCCACATCCCTGAC 
MR03 CATATGAATGGGACTGATATTAAGG 
MR04 GGATCCTTAATACCAGCCGTTAGTTTC 
MR05 ACCGGCAATGCCCAAGCACACGGTAAAAACTACTC 
MR06 GAGTAGTTTTTAC CGTGTGCTTGGGCATTGCCGGT 
MR07 CATATGGCAAAAGCTAAATTTGAACG 
MR08 CTCGAGGCAGCAATGATCTTAGCTACTACAC 
MR09 CACCATGGGTAGTACAGCTAAAACGCTTAC 
MR10 CACCATGGGTAATGGGACTGATATTAAGGCTAAG 
MR11 TTAATACCAGCCGTTAGTTTCG 
MR12 CTACACTTCCACATCCCTGAC 
MR13 GTGCACGGCGCCGTGATTACGGCGTTGCTG 
MR14 CTCGAGTTACTACACTTCCACATCCCTGACC 
 
Table S2. Small Angle X-ray Scattering statistics 
Distance Distribution Rg(Å) Dmax(Å) Estimated 
MW 
HipB 22.812 ± 0.136 79.8 26.0kDa 
HipB:DNA 26.013 ± 0.349 88 38.6kDa 
HipAB 37.133 ± 0.846 128 132.8kDa 
HipAB:DNA 38.584 ± 0.601 132 146.3kDa 
 
 
Table S3. Summary of thermodynamic parameters obtained by ITC. 
 
Titration 
cell 
Conc. 
µM 
Syringe Conc. 
µM 
KD 
nM 
N ΔH 
cal mol-1 
ΔS 
cal mol-1K-1 
HipA 7 HipB 41 490 0.52 -3.429E4 -86.1 
DNA (26bp) 6.8 HipB 63.5 290 1.13 1.381E4 76.2 
HipAD306Q 18.5 HipB:DNA 150.6 300 0.46 -3.167E4 -76.5 
DNA (76bp) 2 HipB 50 230 2.12 1.308E4 74.2 
HipA 13 HipB Nt 
truncated 
103 420 0.44 -3.60E4 -91.5 
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The contents of this chapter adapted from a manuscript: 
Yurong Wen, Bart Devreese. Characterization of Shewanella oneidensis MR-1 HipA-HipB 
Toxin-Antitoxin system Assembly using Mass Spectrometry. 
Under preparation. 
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4.1 Introduction 
As a powerful and increasingly important approach in the field of integrative structural 
biology, mass spectrometry based techniques can give crucial insights in the study of 
supermolecular complex assemblies (See Chapter 2 Introduction section B). After an in-depth 
study of the molecular mechanism by X-ray crystallography, generating an atomic resolution 
three-dimensional structure, and other biophysical techniques (See Chapter 3), we here 
further applied mass spectrometry based techniques, i.e. ion mobility mass spectrometry and 
chemical crosslinking combined with MS to investigate the assembly and to explore the 
molecular mechanism behind the regulation of the type II toxin-antitoxin module HipA-HipB 
in Shewanella oneidensis MR-1. S.oneidensis MR-1 is a gram negative bacteria that is readily 
studied for its potential application in bioremediation, microbial fuel cells and 
nanotechnology (El-Naggar et al., 2010; Gorby et al., 2006; Hau and Gralnick, 2007). All of 
these applications are highly dependent on the capacity of this bacterium to form biofilms. 
We previously reported that interruption of the SO0706 gene in S.oneidensis MR-1 after 
transposon mutagenesis resulted in a 50% of decrease of biofilm formation (Theunissen et al., 
2010).  SO0706 is homologous to the HipA toxin from Escherichia coli with 28% identity. 
HipA, a protein kinase, was demonstrated to be essential for persister formation and 
multidrug tolerance. While it was originally believed that it halted ribosomal activity by 
phosphorylating elongation factor Tu (EF-Tu) (Schumacher et al., 2009, 2012), it was 
recently established that its natural substrate is actually glutamyl-tRNA-synthetase. By 
phosporylating this enzyme at its ATP binding site, uncharged tRNA(Glu) accumulates and 
the stringent response is activated (Germain et al., 2013; Kaspy et al., 2013). The hipA gene 
forms an operon with HipB, a labile antitoxin that neutralizes HipA activity by forming a 
HipAB ternary complex. HipB is a DNA-binding protein that mediates  interactions with 
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operators that are in the upstream of the HipAB operon to reduce HipA expression 
(Schumacher et al., 2009) (Chapter 3).  
We here provide the results of a set of mass spectrometric experiments involving ion mobility 
mass spectrometry and chemical crosslinking experiments that give further insights in the 
S.oneidensis MR-1 HipA-HipB assembly, its regulation and the HipA kinase activity 
mechanism. Firstly, IM-MS results indicate that HipA has three different conformation states, 
i.e. apoHipA, Mg2+-ATP bound HipA and phosphorylated HipA (pHipA).  We show that 
binding of Mg2+-ATP drives the conformational change required for autophosphorylation. 
Secondly, we show that the S.oneidensis MR-1 HipA-HipB assembly is distinct from the 
homologue from E.coli as demonstrated by IMMS and XLMS studies. Finally, our XMLS 
data give further support to the pLoop ejection mechanism as the basis of 
autophosphorylation which is consistent with the data observed from atomic resolution 
structures obtained from X-ray crystal diffraction data. 
 
4.2 Results  
4.2.1 HipA has three different conformational states: apoHipA, ATP bound 
HipA, phosphorylated HipA 
 The HipA family was reported to belong to the Serine/Threonine kinase family with 
similarity to the PI 3/4 kinase super family; it can be partially autophosphorylated in vivo or 
under incubation with ATP and Mg2+ in vitro (Correia et al., 2006). We purified the 
S.oneidensis MR-1 recombinant HipA and applied Ion Mobility MS (IMMS) to characterize 
it. Surprisingly, ion mobility analysis of freshly purified recombinant HipA revealed two 
distinct conformational populations (Figure 4.1a). The two populations from the gas phase 
separation were further extracted using Driftscope analysis (Table 4.1) and the mass 
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difference between the two populations was about 110 Da, which could correspond to a 
phosphorylation in addition to binding a small alkali metal. Indeed, it is previously reported 
that  also E.coli HipA purification results in a partially phosphorylated population and this is 
actually the deactivated form which plays a role in growth arrest reversion (Schumacher et al., 
2012). We further evaluated a tryptic digest of this sample used for IMMS analysis with 
Liquid Chromatography Mass Spectrometry (LCMS) and found that recombinant HipA is a 
mixture of phosphorylated HipA (pHipA) and non-phosphorylated HipA (apoHipA) (data not 
shown). These results further indicated that there is around 8-10% of pHipA that is 
phosphorylated at Ser147.  
In some preparations of the recombinant HipA, we observed that the phosphorylated form 
was nearly absent. When analyzing these samples using IM-MS, only one population was 
observed indicating that the mobility difference is a direct consequence of the 
phosphorylation (Figure 4.1b). Not surprisingly, phosphorylation of HipA results in one 
positive charge reduction. The drift time of pHipA and apoHipA 13+ ions are 9.6ms and 
13.4ms respectively which corresponds to a CCS difference of almost 950Å2 CCS between 
the forms (Figure 4.1c). This cannot be explained by the presence of the phosphate group 
alone, and suggests that pHipA has a more compact conformation compared to apoHipA.  
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Figure 4.1. Results of IMMS measurements of two different preparations of 
recombinant HipA. a. corresponds to a population containing a mixture of apoHipA and 
phosphorylated HipA (pHipA), b. is the nonphosphorylated HipA alone (apoHipA). Both the 
m/z-intensity view and the m/z-drift time view are shown. In the latter, the two populations 
that separated in the gas phase are encircled. c. Drift time chromatogram of the charge 13+ 
pHipA and apoHipA ions with the m/z range from 3880-3960 for apoHipA and 3880-4080 
for pHipA respectively. Calculation of the collision cross section indicated a value of 3800Å2 
for 13+ pHipA and 4750 Å2 13+ apoHipA respectively. d. Schematic view of the three 
different HipA conformations. Upon binding of ATP and Mg2+, apoHipA is phosphorylated 
transforming the protein to a more collapsed pHipA conformation to pHipA. 
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We further analyzed the Mg2+-ATP binding effect on the HipA conformation. Freshly 
purified HipA was incubated with 5mM pH neutralized ATP and 10mM MgCl2.  All 
monomeric HipA shifted to a more compact conformation (Figure S1) (Table 4.1). We 
observed also some oligomeric HipA possibly due to the Mg2+ effect. There is so far no 
evidence for a physiological role for dimeric HipA. However, phosphorylation of HipA was 
reported to be a intermolecules kinetic reaction which means that the autophosphorylation 
strategy is based on one HipA molecules phosphorylating another, requiring the direct 
contact between two HipA molecules with low affinity. Analysis of the tryptic digested 
sample by LCMS indicated that after incubation with ATP and Mg2+, the pHipA ratio 
increased up to approximately 45-50% of the total HipA.  Crystal structure analysis indicated 
that the link between the C-terminal and N-terminal domains of HipA could be flexible and 
that there are five loops between those two domains involved in the ATP and Mg2+ binding to 
HipA. Those five loops form a pocket that could pull together the N and C domains in order 
to tightly anchor the Mg2+-ATP binding, hence resulting in a substantial conformational 
change similar as observed in many kinases. 
Table 4.1 Experimental and theoretical collision cross section and molecular weight 
 apoHipA HipA:ATP:Mg pHipA HipB2* 
HipAB2 
ATP:Mg 
HipA2B2 
ATP:Mg 
Experimental 
CCS(Å2) 4962 3822 3744 2629 5249 8116 
PA S.O. 
CCS(Å2) No data 3628 3576 2585 5273 8143 
PA E.coli 
CCS(Å2) No data 3276 3160 2235 4366 6717 
Experimental 
MW (Da) 50767.6±5.3 51335.7±62.8 50878.1±18.8 
21828.6±1.1 
25343.7±1.6 76658.8±32.8 127940.2±46.9 
Theoretical 
MW (Da) 50764.3 51319.5 50844.3 
21839.2 
25340.8 76660.3 127979.8 
*The two different experimental and theoretical molecular weight indicate the state with or without 
His tag  
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Furthermore, the Mg2+-ATP binding HipA trans-autophosphorylates at S147 residue which 
leads to an additional conformational change through pLoop ejection (Chapter 2). However, 
based on X-ray data, this would lead to a CCS difference of only 52 Å2. Our instrument has 
not the resolution to distinguish such a small conformational change (Figure 4.1d). Therefore, 
the conformational change between the apoHipA and Mg2+-ATP binding HipA results in an 
intermediate conformation state which serves for the HipA phosphorylation.  
4.2.2 Characterization of HipA, HipB and its operator DNA interactions by 
Ion Mobility Mass Spectrometry reveals a distinct assembly with respect to 
S.oneidensis MR-1 and E.coli HipAB complexes 
hipA and its upstream linked gene hipB form a toxin-antitoxin module which is recognized as 
a major factor involved in persistence (Black et al., 1994). HipB is a Helix-Turn-Helix (HTH) 
DNA-binding protein that functions as the antitoxin. It neutralizes HipA activity by forming a 
complex sequestering HipA in the nucleoid following binding to the operators upstream of 
the HipAB operon. Formation of this complex suppresses the transcription of the hipA gene 
(Schumacher et al., 2009, 2012). Here, an IMMS approach was applied to investigate the 
assembly between HipA, HipB and its operator DNA. Native ESI analysis confirmed that 
HipB is a dimer with molecular weight 21343.7±1.6 Da. Similarly, it was determined that this 
dimer interacts with 2 molecules of HipA forming a HipA2B2 heterotetramer with molecular 
weight 127940.2±46.9 Da. Several species including the HipB dimer, HipA monomer, 
HipAB2 and HipA2B2 were nicely separated in the IM mode (Figure 4.2a). Additionally, we 
also performed ESI-MS analysis on HipB in complex with a single operator DNA showing 
that the HipB2 dimer can interact with a single operator DNA fragment (Figure 4.2b). We 
also tested interaction with a DNA fragment containing 2 operator sites showing binding to 2 
HipB2 dimers (Data not shown). 
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To gain more insight into the HipA and HipB assembly, the experimental CCS restraints 
were generated and corrected using the equation reported before (Ruotolo et al., 2008). The 
theoretical CCS of S.oneidensis MR-1 and E.coli HipAB assembly was calculated by 
applying the Projection Approximation (PA) mode using the PDB data files (3DNV, 3FBR, 
3TPE) containing the atomic resolution crystal structures (Schumacher et al., 2009, 2012). 
The experimental CCSs of the protein assembly are well correlated in a nice linear 
relationship with R2 value 0.9961. This represents a very important value representing the 
solvent accessible surface area (SASA) in the globular protein with the unit of Å2/Da. The 
SASA per Da of the apoHipA decreases from 0.098 Å2/Da to 0.073 Å2/Da upon the Mg2+-
ATP binding, revealing that the ATP and Mg2+ occupied region of the exposed surface is the 
link between the N and C domain. The experimental CCS and theoretical CCS generated with 
the PA model from S.oneidensis MR-1 crystal structure nicely fit with a tiny deviation of 2-
4%. However, the theoretical CCS of the E.coli homologue HipA and HipB assembly are 
considerable different from the S.oneidensis MR-1 experimental CCS (Figure 4.2c). This 
indicated that the toxin antitoxin system HipAB assembly between E.coli and S.oneidensis 
MR-1 are distinct as consistent with the data observed from the atomic structure (Chapter 2). 
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Figure 4.2. a. The IMMS measurement of the HipAB. Both the m/z-intensity view and the 
m/z-drift time view are shown, the charges of the 4 populations are denoted, B: HipB2, A: 
HipA, C: HipAB2, D: HipA2B2. The 4 populations are also circled in the m/z-drift time view. 
b. native ESI-MS measurement of HipB2DNA complex, the charge of the populations is 
denoted B: HipB2, E: HipB2DNA. c. The experimental and the theoretical PA model CCS are 
shown with the molecular weight correlation. The experimental HipB2, HipA, HipAB2, 
HipA2B2 CCS has significant linear correlation with molecular weight with R2 0.9961. The 
S.oneidensis experimental CCS has nicely fit the S.oneidensis theoretical PA calculation and 
the dramatically difference between the S.oneidensis experimental CCS and E.coli PA model 
CCS represent the distinct assembly between the S.oneidensis and E.coli. 
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4.2.3 Probing the HipA kinase conformational changes upon 
phosphorylation using chemical crosslinking 
Chemical crosslinking was used to probe the assembly of S.oneidensis MR-1 HipA and HipB 
complexes. After BS3 crosslinking, tryptic peptides were generated and analyzed using 
LCMS on a high resolution FTMS instrument. Data were analyzed using pLink software 
which revealed 6 crosslinked peptides  including both inter- and intra-crosslinked peptides 
(Yang et al., 2012)  (Table 4.2).  
Table 4.2 Crosslinked peptides between HipA and HipB assembly identified by pLink 
No. Sequence 1 
X-linked position 
Sequence 2 
X-linked position 
Scor
e 
Calc_M ppm 
1 IEDPTMWPMEIWDGKPR(15) 
HipA(143) 
DVKDIR(3) 
HipA(264) 
7.41
E-04 
2982.46
2 
0.30166 
 
2 RKSAALTQDVAAMLCGVTK(2) 
HipB(39) 
KYER(1) 
HipA(252) 
8.57
E-02 
2694.42 
 
0.62327 
 
3 VEKGEDVYISTVFK(3) 
HipB(64) 
KTLIR(1) 
HipB(57) 
9.95
E-09 
2380.32
5 
0.01259 
 
4 VYEDTLLETIMASPLNQQSLGLLIKER(25) 
HipB(35) 
VEKGEDVYISTVFK(3
) 
HipB(64) 
4.36
E-02 
4824.54 
 
1.27446 
5 VEKGEDVYISTVFK(3) 
HipB(64) 
GSHMNGTDIK(1) 
HipB(-2) 
9.56
E-02 
2809.38
4 
-4.66484 
6 VYEDTLLETIMASPLNQQSLGLLIKER(25) 
HipB(35) 
GSHMNGTDIK(1) 
HipB(-2) 
8.44
E-01 
4270.18
6 
-0.89202 
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Figure 4.3. Results of crosslinking experiments using BS3. a. The crosslinked peptides are 
denoted on the S.oneidensis MR-1 HipA2B2 3D dimensional structure accompanied with the 
distance restraints. b The ms/ms spectrum of the crosslinked peptide K143 and K264 c. The 
K143 and K264 crosslinked peptide in the pHipA and ATP-mimic binding HipA. The 
distances are 18.6Å and 40.3Å respectively indicating that in the AMPPNP bound HipA, the 
distance between these residues is too large and cross-linking is further hindered by a helical 
structure. The observation of the crosslinked K143 and K264 in the pHipA thus probes the 
pLoop ejection upon of HipA phosphorylation.  
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The spacer length of the BS3 crosslinker is 11.4Å and an efficient crosslink distance between 
two   lysine   residue   Cα   atoms   is reported to be approximately 5-30Å (Leitner et al., 2012; 
Walzthoeni et al., 2012; Yang et al., 2012). Distance restraints are generated and nicely fit the 
values reported for BS3 crosslinkers (Figure 4.3a). It is noteworthy that two distinct 
crosslinked sites (K35 and K64) were observed from the N terminus domain of HipB, which 
could be due to the flexibility of the HipB N terminus domain. Surprisingly, when we applied 
the chemical crosslinking approach to a pHipA containing sample, an additional crosslinked 
peptide was observed between K143 and K264.  K143 is positioned inside the reported 
phosphorylation loop (pLoop) of which repositioning is crucial for the activation of the 
kinase activity of HipA. Interestingly, this crosslink was not observed in the HipAD306Q 
mutant which was reported not to undergo phosphorylation. The MS/MS fragmentation 
spectrum of this crosslinked peptide was highly confident with most of the b and y ions 
generated (Figure 4.3b). Indeed, from the crystal structure of pHipA and the AMPPNP bound 
HipA, the distance observed between K143 and K264 are 18.6Å and 40.3Å respectively 
(Figure 4.3b). Those two residues are too far away to be crosslinked and, moreover, they are 
separated by a helix in both the apoHipA and in HipA bound to the ATP-mimicking 
compound AMPPNP. This indicates that the K143 and K264 crosslinked peptide observed 
from the pHipA describes the phosphorylation pLoop conformational change which we could 
not observe using ion mobility experiments. 
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4.3 Discussion 
Mass spectrometry combined with ion mobility and chemical crosslinking was dedicated to 
be powerful in study of protein dynamics such as protein-ligand interaction, conformational 
change and transition interactions. In this study, three different conformations of recombinant 
HipA were observed in ion mobility MS experiments, indicating the HipA kinase activation 
procedure going from the apoHipA, ATP Mg2+ binding to autophosphorylation. ESI-IM-MS 
also specializes at probing the weak non-covalent protein-protein interactions; the 
observation of dimeric HipA upon ATP and Mg2+ could reflect the trans-autophosphorylation 
between two HipA molecules. Furthermore, the HipA kinase activity loop ejection 
mechanism was characterized through the chemical crosslinking mass spectrometry approach. 
The native ion mobility mass spectrometry data represent good correlations with the atomic 
resolution model provided in the previous chapter and revealed a distinct assembly between 
E.coli and S.oneidensis MR-1 HipAB and their DNA binding structure.  
Here, the successful characterization of the S.oneidensis MR-1 HipA-HipB assembly and 
mechanism through combination b IMMS and XLMS established an example of gathering 
information on macromolecular assembly using MS approach. Adding MS to an integrative 
structural biology approach can complement the crystallography challenge such as non 
crystallizable   and   constituents’   transient   interactions. Recently, these mass spectrometry 
approaches were summarized to be applicable in  pharmaceutical drug discovery and 
development in applications to study the conformational transition and protein ligand 
screening (Niu et al., 2013; Pacholarz et al., 2012). The toxin antitoxin systems are 
demonstrated as an attractive target for new generation antimicrobial drug discovery which 
may aid in the fight to major challenges under current antibiotic treatment such as persistence, 
multidrug tolerance and multidrug resistance  etc…(Shapiro, 2013; Wen et al., 2014; Williams 
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and Hergenrother, 2012).  The successfully probing of the conformation change between the 
HipA with its ligand binding and post-translational modification revealed the potential of the 
mass spectrometry based approach in the investigation of protein ligand complexes and may 
further lead to the pharmaceutical exploitation of the toxin antitoxin system as drug targets. 
 
4.4 Experimental procedures 
4.4.1 Preparation of Protein and Protein-DNA complex Samples 
S.oneidensis MR-1 HipA, HipB proteins with an N-terminal His-tag were expressed in E.coli 
BL21 DE3 cells using the pET15b expression vector (Merck Millipore). Stable 
overexpression of the target proteins was generated by inducing the cultures for 1 h (HipA) or 
4h (HipB)  with   1mM   isopropyl   β-D-1-thiogalactopyranoside (IPTG) (Duchefa Biochemie) 
when cultures were grown to an OD600 of 0.6-0.7 in LB medium supplied with Carbencillin 
(100µg/ml) at 37ºC. Detailed overexpression and purification protocols were previously 
described (See Chapter 2). The double stranded operator DNA obtained from annealing two 
single   primers   5’-ATTAGGTGTACTTATCTACACTTTTT-3’,   5’-
AAAAAGTGTAGATAAGTACACCTAAT-3’   for   the   following   purification   (IDT).   The  
HipAB and HipB:DNA complex were formed by mixing proper ratios and subsequently 
purified by Superdex 200 chromatography column (GE). The concentrations of the samples 
are determined with Nanodrop (Thermo Scientific). 
4.4.2 ESI Ion mobility MS Analysis 
Purified samples with a protein concentration of 10-20µM were buffer exchanged against 
100-200mM ammonium acetate buffer pH 7  using Micro Biospin 6 columns (Bio-Rad) just 
prior to MS analysis. The HipA-ATP-Mg samples were obtained by adding 5mM ATP 
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(Sigma) and 10mM MgCl2 to the buffer exchanged sample before the MS measurement. The 
traveling wave ion mobility MS measurements were performed on a q-IMS-TOF instrument 
Synapt G1 HDMS, Waters, UK) equipped with a nanomate electrospray ionization source 
(Advion).  The buffer exchanged samples were sprayed using a capillary voltage of 1.65-
1.75kV using the type D nano-ESI chip. The IM separator was pressurized with 0.5mbar. The 
applied traveling wave parameters were: Ion mobility wave velocity 400m/s, wave height 12. 
Ions underwent TOF analysis with m/z range from 1500 or 2000 to 8000. The TOF tube 
vacuum pressure maintained at around 9.5×10-7 mbar. All the other instrument parameters 
were tuned by following the protocol reported before (Ruotolo et al., 2008). All the data was 
analyzed using Masslynx V4.1 and DriftScope V2.3 (Waters) with minimal smoothing and 
background subtraction. 
4.4.3 Chemical Crosslinking proteolysis and LC-MS analysis of crosslinked 
peptides 
Bis[sulfosuccinimidyl] suberate (BS3, Pierce) was the crosslinker used in the crosslink 
experiment. We prepared a stock concentration of 100mM or 200mM BS3 in water. For the 
crosslinking conditions optimization, different BS3 concentration 0mM, 0.5mM, 1mM, 2mM 
and 5mM, the incubation time of 15min, 30min, 45min, 60min and 120min were used. The 4 
degree and room temperature condition were also tested and the final crosslinking approach 
was used and described below. Finally, the crosslinker BS3 concentration of 1mM or 2mM 
were used with 45-60mins incubation time in the room temperature.  After final concentration 
of 1mM or 2mM of BS3 was added to the purified protein or protein complex and the 
mixture was incubated at room temperature for 45-60min, the reaction was quenched by the 
addition of Tris buffer pH7.0 to a final concentration of 50mM. The sample was subsequently 
digested overnight with trypsin (Porcine sequencing grade, Promega) at 37 degrees using an 
enzyme to protein ratio of 1:20. The sample was buffer exchanged on a Superdex peptide PC 
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3.2/30 column and to enrich the peptides, the fractions eluted out from 0.9-1.5ml was 
collected, dried and dissolved using 0.1% formic acid aqueous solution prior to LCMS 
analysis. The digests were analyzed by nanoESI LCMS/MS using an Agilent 1200 HPLC at a 
flow rate 300nL/min. A C18 Acclaim PepMap300 5µm (Thermo Scientific Dionex), trapped 
the peptides followed by separation on a C18 Acclaim PepMap100 (3µm) 75µm×250mm 
column (Thermo Scientific Dionex). Peptides were eluted with a gradient of acetonitrile. 
Buffer A contained 0.1% formic acid in water and buffer B was 0.1% formic acid in 
acetonitrile. The applied gradient was:  2%B to 10%B in 10min, 10%B to 40%B in 30min, 40% 
to 80% in 10min, and 80% to 2% in 5min. The column outlet was directly interfaced to a 
nanoflow electrospray source (Advion) equipped with D-chips connected to an LTQ-FT 
Fourier transform ion cyclotron resonance Mass spectrometer (Thermo). Data dependent 
analysis was carried out using a resolution of 100000. MS spectra were acquired over an m/z 
range of 150-2000 with a charge filter above 1 and the 10 highest peaks were submitted to 
MS/MS scans using a threshold energy of 35v for collision induced dissociation (CID). The 
chemical crosslink data analysis was performed using the pLink program (Yang et al., 2012). 
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Chapter 5 
Modeling Pseudomonas aeruginosa Type II 
Secretion System XcpP and XcpQ Periplasmic 
Domain Assembly via Mass Spectrometry Based 
Integrative Structural Biology 
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Savvides. Multiple binding interactions between XcpP and XcpQ from the type II secretion 
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Savvides. XcpP from the type II secretion system from Pseudomonas aeruginosa dimerizes 
via its transmembrane helix. Under preparation.  
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5.1 Introduction 
Pseudomonas aeruginosa is a gram negative opportunistic human pathogen involved in a 
wide range of human infections, especially in patients having a compromised host defense 
mechanism.  The bacterium is identified as one of the most prominent pathogens isolated 
from cystic fibrosis patients and is a frequent cause of nosocomial infections 
(http://www.pseudomonas.com/). P.aeruginosa uses specific structures such as the pili to 
adhere to the surface of the host epithelial cells such as in human lungs . The successful 
adhesion and colonization of P.aeruginosa on the host tissue, ultimately leading to infection, 
highly relies on its capacity to secrete diverse virulence factors, such as exotoxins and 
proteolytic enzymes (Bleves et al., 2010; Davies, 2002; Gerlach and Hensel, 2007). Examples 
of such well characterized exoproteins in P.aeruginosa are Exotoxin A and pseudolysin. The 
interaction and transportation between the bacteria and the host organism or extracellular 
space are highly dependent on bacterial secretion systems. Bacterial secretion systems are 
multicomponent supramolecular assemblies involved in translocation of macromolecules 
such as effector proteins, nucleic acids and complexes across both the inner and outer 
membrane of bacteria. 
At present, in gram negative bacteria, six different classes of secretion systems have been 
described, going from so called type I secretion system (T1SS) to type VI secretion system 
(T6SS) (Economou et al., 2006). T2SS and T5SS are demonstrated to use a two-step process 
with firstly a transfer of the exoprotein into the periplasm and then to the extracellular milieu. 
The translocation from the cytoplasm to periplasm is established by the inner membrane 
universal general secretion (Sec) or twin-arginine (Tat) machineries which are responsible for 
transport of unfolded and folded or partially folded proteins respectively. These two secretion 
systems are specific by recognizing dedicated cleavable N-terminal signal peptides. T1SS, 
T3SS, T4SS and T6SS have been shown to use a single step strategy to transport the 
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exoprotein into the extracellular environment (T1SS) or into the host cell (T3SS, T4SS and 
T6SS). Instead of having a common signal peptide recognition mechanism, those systems are 
driven by a secretion signal which differs from one system to another (Chandran, 2013; 
Douzi et al., 2012; Fronzes et al., 2009; Korotkov et al., 2012; Miyata et al., 2013; Tseng et 
al., 2009) (Figure 5.1). In addition, Gram positive bacteria share some secretion systems with 
gram negative bacteriasuch as the ESX  system (also defined as T7SS) described in 
Mycobacterium tuberculosis (Simeone et al., 2009). 
 
 
Figure 5.1 Schematic presentation of six bacterial secretion systems in gram negative 
bacteria.  The outer membrane protein secretin is shown in pink, ATPase and chaperones are 
shown in blue, the pseudopilins are shown in yellow. Adapted from KEGG. 
 
In P.aeruginosa, five out of these six gram negative bacterial secretion systems have been 
identified and characterized, except T4SS. Here we will mainly focus on the T2SS which is 
one of the most versatile systems used in gram negative bacteria. In general, T2SS is known 
as the general secretory pathway (Gsp) and has been named as GspC to M and GspO in 
Escherichia coli. However, the nomenclatures of its homologues in different strains have 
different names which are listed in Table1. Therefore, the P.auruginosa specific terms XcpPC, 
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XcpQD, XcpZM and XcpAO will be used in this chapter, where the subscript refers to the Gsp 
annotation. 
 T2SS usually contains 12-16 different protein subunits which are mostly encoded in a single 
operon. However, In P.aeruginosa the T2SS is encoded in two operons with the one of XcpP 
and XcpQ being different from that of the others XcpR to XcpZ, whereas the XcpA does not 
locate in the same cluster as the other subunits  (Bleves et al., 2010; Sandkvist, 2001; 
Sandkvist et al., 2001).    
 
Table 5.1 Composition and species specific nomenclature of the T2SS. The general 
secretory pathway (Gsp) prefix has been suggested for use in all type II secretion systems 
(T2SSs), but this nomenclature from E.coli is not universally used. This table shows the 
species and systems specific names only from the best characterized bacteria species. 
Adapted from (Korotkov et al., 2012) 
 
In P.aeruginosa, the T2SS machinery can be distinguished into 5 subassemblies: outer 
membrane secretin (XcpQD), the pseudopilus (XcpTG, XcpUH, XcpVI, XcpWJ, XcpXK), the 
inner membrane platform (XcpPC, XcpSF, XcpYL and XcpZM), the secretion ATPase (XcpRE) 
and the prepilin peptidase (XcpAO). Recently, based on numerous biochemical and structural 
studies, several hypothetical action mechanisms for T2SS were proposed using E.coli Gsp 
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system as the model organism. In general, the exoprotein, for example, the cholera toxin AB5 
is first transported from cytoplasm through Sec to the periplasm, refolds and assembled in the 
functional form. The exoprotein is recognized by the secretin or by GspC and a signal is 
possibly transmitted to the ATPase GspE. The energy from the ATP hydrolysis drives the 
motions to the pseudopilin coupling protein GspL and results in the growth of the pseudopilin 
assembly GspG to further push out the exoprotein (Douzi et al., 2012; Korotkov et al., 2012; 
McLaughlin et al., 2012) (Figure 5.2). Despite plenty of biochemical and functional studies 
on bacterial T2SS, there exist still quite some gaps to completely understand the molecular 
basis of this bacterial machinery.  
 
Figure 5.2. A hypothetical mechanism of action for the Type II Secretion System (T2SS). 
The ATPase GspE is in orange, the inner membrane platform proteins are in green, the 
pseudopilins GspKIJ is shown in silver and GspG is shown in pink, the outer membrane 
secretin GspD is in blue, and the exoprotein in this case is cholera toxin is shown in yellow. 
Adapted from (Korotkov et al., 2012).  
 
Firstly, it is still yet unknown how the substrates are recognized by the T2SS machinery and 
what is the profile of those substrates; secondly, it is questioned how the secretion ATPase 
XcpRE constantly supplies the energy to drive the pseudopilins to push out the substrates; 
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thirdly, we do not understand how the XcpPC or secretin XcpQD recognize the substrates and 
how they manage to open and close to release the substrates of secretion. For the latter, the 
subunit XcpPC is thought to play a key role as it bridges the inner membrane, periplasmic 
space and the outer membrane secretin XcpQD (Korotkov et al., 2011). Therefore study of the 
assembly of XcpPC and XcpQD is crucial to understand the transport machinery. 
XcpPC is an inner membrane protein with a large periplasmic domain which can directly 
interact with the outer membrane secretin  (Douzi et al., 2011). It includes an N-terminal 
transmembrane domain (TM), a homologue region domain (HR), a coiled coil domain (CC) 
and linkers between those domains, the HR domain which is the most conserved domain 
contains  6  β  strands  (β1-β6)  (Bleves et al., 1999; Gérard-Vincent et al., 2002). XcpQD is the 
outer membrane secretin, having a 35 residues N-terminal signaling sequence and 4 
periplasmic N-terminal domains (N0, N1, N2, N3), and a highly conserved outer membrane 
C-terminal  β  barrel  domain  which  is  speculated to form a dodecameric cylindrical structure 
(Reichow et al., 2010) (Figure 5.3).  Recently, the crystal structure of  the periplasmic domain 
N0 of enterotoxigenic E.coli secretin GspD was also shown to be organized in a dodecameric 
assembly (Korotkov et al., 2013). 
 
 
Figure 5.3. Schematic diagram of the P.aeruginosa XcpPC and XcpQD protein domain 
structure 
 
In the enterotoxigenic E.coli system,  the  N0  domain  β1 of GspD is involved in the interaction 
with   the   inner   membrane   platform   protein   GspC   HR   domain   β1   (Korotkov et al., 2011). 
However, a Surface Plasmon Resonance (SPR) and pull down interaction study has shown 
Integrative Structural Biology & Type 2 Secretion System 
131 
that, in the P.aeruginosa Xcp system, the XcpQD N-terminus can interact with XcpPC only 
when the N3 domain is present (Douzi et al., 2011). More recently, a cysteine scanning 
mutagenesis and disulfide mapping analysis study indicated that the GspC and GspD interact 
in  multiple  transient  ways.  OutC  (GspC)  HR  domain  β1  and  β6  was  reported  to  interact  with  
both the N0 and N2N3 domain of OutD (GspD) in E.coli and Erwinia chrysanthemi (Wang et 
al., 2012). Furthermore, it was also shown that, in the E.chrysanthemi Out system, a 20 
residues   peptide   from   the  HR   region   β5   and   β6   of   the   inner  membrane   protein   OutC   can  
interact with two distinct regions of the outer membrane secretin OutD, which located in the 
N0 and N2N3 domain respectively (Login et al., 2010). In short, how exactly the XcpPC 
interact with XcpQD in the periplasmic is still a debate. Therefore, we here apply multiple 
biophysical and biochemical approaches to investigate their assembly and dynamic 
association. 
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5.2 Results 
5.2.1 Mass Spectrometry Characterization of P.aeruginosa XcpPC and 
XcpQD  
To probe the interaction between XcpPC and XcpQD, multiple constructs were designed and 
the respective proteins were purified (Figure 5.4a). The quality of the overexpression and 
purification of a protein product is crucial for structural and functional investigations. In this 
project, we applied the techniques of peptide mass fingerprinting and intact protein mass 
analysis for the validation of our samples. The molecular weight of the purified protein was 
measured using ESI MS. For example, MS analysis of the product of the XcpPC HRCC 
construct indicated a good fit between the theoretical and experimental mass (Figure 5.4b). 
During the process of overexpression and purification, unexpected modifications may be 
introduced to the samples by post-translational modifications or partial polypeptide cleavage. 
Highly accurate mass determination of the sample product can definitely benefit further 
investigation. For example, after a thrombin cleavage of the XcpQD N0N3’  His-tag protein, a 
mass of 26548Da was obtained from ESI MS measurement apparently resulting from an 
unexpected miss cleavage in the N3 domain, simultaneous with cleavage of the His-tag. The 
difference between the theoretical and experimental mass indicated that the obtained product 
was actually 5 residues (273-277 TPTAR) longer than the N0N2 (35-272) domain, with 48 
(278-325) of the residues miss-cleaved from the C-terminus of the N3 domain, further 
designated  as  N3’   (Figure  5.4c). Surprisingly, this protein product was further successfully 
applied for crystallization and structure determination (Van der Meeren et al., 2013).  
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Figure 5.4. a. The schematic diagram of the P.aeruginosa XcpPC and XcpQD constructs used 
in this study. b. Measurement under denature condition of intact XcpPC HRCC shows a good 
correlation of the theoretical and experimental mass. c. Measurement under denaturing 
conditions of intact XcpQD N0N3 revealed there was a thrombin miss-cleavage during 
sample preparation. 
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Aside from being crucial to verify the quality of the samples that we are working with, intact 
ESI MS measurements under native conditions can give significant insight in the state of the 
structural assembly of complex such as the oligomeric state, the binding stoichiometry and 
even a low resolution model of the complex assembly (See also chapter 3 and 4).  Here, we 
also applied the ESI IM MS approach for the investigation of the XcpPC and XcpQD 
periplasmic domain assemblies. XcpQD is  thought  to  form  a  dodecameric  β  barrel  structure  in  
the outer membrane, and based on the crystal structure of monomer GspD in complex with 
nanobody protein Nb7, the periplasmic domain of GspD in ETEC was reported to form a C12  
symmetry assembly (Korotkov et al., 2009). However, the P.aeruginosa XcpQN0N3’  protein 
crystallizes in a dimeric form and it was shown that the Nb7 could have blocked the interface 
of the dimerization of the reported GspD structure (Van der Meeren et al., 2013). The wild 
type of XcpQD N0N3’  exists  in  a  mixture  of  monomer  and  dimer  (Figure  5.5a). Furthermore, 
it was demonstrated that the XcpQD N0N3’  can  form  a  dimer   in  a  concentration  dependent  
way as proved by native ESI-IM-MS, Size Exclusion Chromatography (SEC) and Small 
Angle X-ray   Scattering   (SAXS).  The  mutation   S210C   in  XcpQN0N3’  which   resulted   in   a  
disulfide bridge formation is also only detected in dimeric form in solution and further 
crystallizes in the same packing as the wild type (Figure 5.5b). In conclusion, we have 
demonstrated that the P.aeruginosa T2SS secretin XcpQD periplasmic domain is a dimeric 
protein which most likely oligomerizes into a functional dodecameric assembly with C6 
symmetry (Van der Meeren et al., 2013). 
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Figure 5.5. a. The P.aeruginosa XcpQD N0N3’   is   a   mixture   of   monomer   and   dimer   in  
solution indicated in both m/z intensity and m/z drifttime view. The M and D denote the 
charge of the monomer and dimer b. The S210C mutant of P.aeruginosa XcpQD N0N3’  
forms a dimer in solution, the S210C mutation site is shown in sphere between the interfaces 
of the dimerization. 
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5.2.2 Study of the P.aeruginosa XcpP and XcpQ Assembly using Chemical 
Crosslinking and Mass Spectrometry 
Chemical crosslinking combined with mass spectrometry has become one of most successful 
approaches in the characterization of macromolecular assemblies (Chapter 3). Here we 
applied different crosslinkers to investigate the interaction between the XcpPC and XcpQD 
periplasmic domains. Initially, formaldehyde crosslinking experiments with different 
constructs of P.aeruginosa XcpPC and XcpQD were performed. It is shown that XcpPC HR, 
HRCC and XcpQD N0N2 but not the XcpPC CC can form higher oligomeric states lane 2, 4, 
5 and 3 respectively. Furthermore, XcpPC HR, XcpPC HRCC, but not XcpPC CC could 
interact with XcpQD N0N2 using formaldehyde crosslinking lane 6, 8 and 7 respectively. All 
the crosslinked bands were further verified by peptide mapping fingerprint (Figure 5.6). 
 
Figure 5.6. The formaldehyde crosslinking experiment with different constructs of 
P.aeruginosa XcpPC and XcpQD. The right panel denotes the product used for the 
crosslinking experiment. The red stars indicate the bands corresponding to the crosslinked 
products. 
 
The formaldehyde crosslinking experiment reveals that the XcpPC and XcpQD periplasmic 
domains can exist in an oligomeric state in solution, which also fits the results obtained by 
native mass spectrometry (Data not shown for XcpPC). It is also shown that the XcpPC using 
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its HR domain but not its CC domain can interact with the XcpQD N0N2 domain in the 
absence of the N3 domain. This is surprising as a previous report stated that the XcpPC 
interacts with XcpQD only when the full N3 domain is present (Douzi et al., 2011). 
After successful observation of the interaction between P.aeruginosa XcpPC and XcpQD 
periplasmic domains from the formaldehyde crosslink experiments, we further refined the 
approach to identify the crosslink site, and to build the assembly network. Building on the 
recent development of algorithms for large scale crosslinked peptide identification and 
improvement of false discovery rates, we applied BS3 and DSS as the crosslinkers for further 
investigation (See also chapter 3). The spacer lengths of the BS3 and DSS crosslinkers are 
11.4Å and the efficient crosslink distance between two lysine  residue  Cα  atoms  are  reported  
approximately from 5-30Å (Leitner et al., 2012; Walzthoeni et al., 2012; Yang et al., 2012). 
The main procedures that are involved in the chemical crosslink mass spectrometry approach 
are featured in Figure 5.7.  We have carried out an in vitro crosslink strategy using the 
different purified protein constructs as well as an in vivo crosslink strategy which directly 
applies the crosslinker to the whole P.aeruginosa PAO1 cell and the cell membrane. Here we 
will only present the results of the in vitro crosslink, since the in vivo crosslink is still under 
way. 
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Figure 5.7. The schematic view of the chemical crosslinking mass spectrometry 
approach. 
 
 The crosslink database search was mainly performed using pLink and pFind software 
platforms and the homology models were generated using the Swiss-Model workspace 
(http://swissmodel.expasy.org/). A total of 987 MS/MS spectra containing crosslinked 
peptides ms/ms spectrum where obtained and could be grouped in 33 peptides from the 
P.aeruginosa XcpPC and XcpQD periplasmic domains using BS3 as the crosslinker. Those 
crosslinked peptides were further screened and verified, with 16 of the most significant 
(FDR<5%) ones being used for the structural modeling (Table 5.1). 
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Table 5.2 the crosslinked peptides between P.aeruginosa XcpP and XcpQ periplasmic domain 
# represents the detection of one m
iss cleavage site in the peptide 
* In the hinge dom
ain that links X
cpQ
N
2 and X
cpQ
N
1 
 
Protein Position 
Sequence 1 
 (X
-linked R
esidue N
o.) 
Sequence 2  
(X
-linked R
esidue N
o.) 
D
om
ains 
XcpQ intra and inter crosslinked peptides 
X
cpQ
(292)-X
cpQ
(263) 
H
N
D
A
K
TLA
ETLG
Q
ISEG
M
K
(5) 
A
K
LV
Q
LA
Q
SLD
TPTA
R
(2) 
N
3-N
2 
X
cpQ
(263)-X
cpQ
(263) 
A
K
LV
Q
LA
Q
SLD
TPTA
R
(2) 
A
K
LV
Q
LA
Q
SLD
TPTA
R
(2) 
N
2-N
2 
X
cpQ
(263)-X
cpQ
(236) 
A
K
LV
Q
LA
Q
SLD
TPTA
R
(2) 
G
Q
A
K
G
A
A
G
A
Q
V
IA
D
A
R
(4) 
N
2-N
2 
X
cpQ
(236)-X
cpQ
(236) 
G
Q
A
K
G
A
A
G
A
Q
V
IA
D
A
R
(4) 
G
Q
A
K
G
A
A
G
A
Q
V
IA
D
A
R
(4) 
N
2-N
2 
X
cpQ
(236)-X
cpQ
(204) 
G
Q
A
K
G
A
A
G
A
Q
V
IA
D
A
R
(4) 
Q
LD
Q
K
G
SH
D
Y
SV
IN
LR
(5) 
N
2-N
2:N
1
* 
X
cpQ
(131)-X
cpQ
(84) 
IV
PN
A
EA
K
TEA
G
G
G
Q
SA
PD
R
LETR
(8) 
V
K
G
Q
V
SV
V
SK
(2) 
N
0-N
0 
X
cpQ
(84)-X
cpQ
(84) 
V
K
G
Q
V
SV
V
SK
(2) 
V
K
G
Q
V
SV
V
SK
(2) 
N
0-N
0 
XcpP intra and inter crosslinked peptides 
X
cpP(143)-X
cpP(128) 
Y
A
V
G
G
EISD
G
V
K
LH
A
V
Y
R
(12) 
Q
G
D
K
PH
R
(4) 
H
R
-H
R
 
X
cpP(143)-X
cpP(116) 
Y
A
V
G
G
EISD
G
V
K
LH
A
V
Y
R
(12) 
G
SFV
Q
SD
PK
LSSA
IIQ
R
(9) 
H
R
-H
R
 
X
cpP(128)-X
cpP(128) 
Q
G
D
K
PH
R
(4) 
Q
G
D
K
PH
R
(4) 
H
R
-H
R
 
X
cpP(116)-X
cpP(128) 
G
SFV
Q
SD
PK
LSSA
IIQ
R
(9) 
Q
G
D
K
PH
R
(4) 
H
R
-H
R
 
X
cpP(116)-X
cpP(128) 
G
SFV
Q
SD
PK
LSSA
IIQ
R
(9) 
LSSA
IIQ
R
Q
G
D
K
PH
R
(12) # 
H
R
-H
R
 
X
cpP(116)-X
cpP(128) 
LFG
TSA
Q
D
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A
PPPA
TN
LD
LV
LK
G
SFV
Q
SD
PK
(23) # 
Q
G
D
K
PH
R
(4) 
H
R
-H
R
 
XcpP and XcpQ inter crosslinked peptides 
X
cpQ
(263)-X
cpP(128) 
A
K
LV
Q
LA
Q
SLD
TPTA
R
(2) 
Q
G
D
K
PH
R
(4) 
N
2-H
R
 
X
cpQ
(236)-X
cpP(128) 
G
Q
A
K
G
A
A
G
A
Q
V
IA
D
A
R
(4) 
Q
G
D
K
PH
R
(4) 
N
2-H
R
 
X
cpQ
(84)- X
cpP(128) 
V
K
G
Q
V
SV
V
SK
(2) 
Q
G
D
K
PH
R
(4) 
N
0-H
R
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The P.aeruginosa XcpQN0N2 crystal structure (PDB: 4E9J) and the XcpPHR domain 
structure model obtained from the Swiss-Model workspace using the E.coli GspC structure 
(PDB: 3OSS or 2LNV) as the template are used for the structural modeling. The XcpP HR 
domain,  predicted  to  contain  a  6  β  strand  structure  is  the  most  conserved  region  in  this  T2SS  
inner membrane protein and is the crucial domain for binding the outer membrane secretin 
XcpQ periplasmic domain (Figure 5.8).  
 
Figure 5.8. Sequence alignment of E.chrysanthemi OutC, E.coli GspC and P.aeruginosa 
XcpP. The red square box from E.chrysanthemi OutC represents the secretin interaction 
segment (139-159,   β5   and   β6) that interacts with two distinct regions with OutD N0 and 
N2N3. The black square box from E.coli GspC  HR  domain  β1  represents  the  interface  with  
GspD  N0  domain  β1. 
 
The XcpPC HR  domain  region  β3  K128  is  observed  to  be  crosslinked  with  both residues from 
the XcpQD N0 and N2N3 domain. This crosslink site could manage the interaction interface 
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to access the fragment that is highly homologous with the OutC 20 residue secretin 
interaction peptide (SIP) (139-159,  β5  and  β6)  which  was  reported  to  be  essential  to  interact  
with two distinct domains of OutD (Login et al., 2010) as  well  as  the  GspC  HR  domain  β1  to  
interact with GspD N0 domain (Korotkov et al., 2011) (Figure 5.8). 
The crosslinked sites were first validated with the known structural models of the XcpPC HR 
domain and XcpQD N0N2 domains. The intramolecular cross linked residues from XcpQD 
are at two interfaces of the XcpQD N0N2 dimer. and all the crosslinked lysine residues are at 
a distance within the range amenable for crosslinking according to reported values (Hall et al., 
2012; Leitner et al., 2012) (Figure 5.9a). The crosslink sites network is further shown in the 
overall domain view, with both inter- and intramolecules crosslink sites of XcpPC and XcpQD 
being denoted. Especially noteworthy are the 3 intermolecular crosslinked sites, the ones 
between XcpPC HR K128 and, respectively, the XcpQD N0 domain K84 and XcpQ N2N3 
domain K236 and K263 (Figure 5.9b).  Since it is impossible for the XcpPC HR domain to 
interact with two distinct domains of XcpQD simultaneously, this suggests that there are two 
different interaction interfaces for the periplasmic XcpPC and XcpQD. This is indicative for 
the two states of binding states (Figure 5.9c). Examples of some crosslinked peptides MS/MS 
spectra generated from pLink are denoted (Figure 5.9d) (See also Chapter two: Introduction 
Section B). 
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Figure 5.9. a. Validation of the crosslinked peptide distance restraints with the known crystal 
structure of XcpQD N0N2 and the homologue model XcpPC HR, the lysine residues involved 
in the crosslinking are shown in red sphere accompanied with the distances. b. Schematic 
view of the crosslinked sites, the black straight lines indicate the inter crosslink in XcpPC or 
XcpQD, the red dash lines indicate the inter crosslink between XcpPC and XcpQD. c. Two 
distinct interaction interfaces of the XcpPC HR domain to the XcpQD N0 domain and XcpQD 
N2N3 domain are indicated in green I1 and I2. d. Examples of the crosslinked peptides 
MS/MS spectra generated with pLink. 
 
 
 
 
 
 
 
 
 
 
5.3 Discussion and Perspective 
We have carried out a mass spectrometry based approach to study the assembly of 
P.aeruginosa XcpPC and XcpQD. Although the analysis is not comprehensive, multiple 
features are observed concerning the machinery assembly. The crosslinking data suggested 
multiple interaction interfaces in the periplasmic domains between XcpPC and XcpQD.  This 
is compatible with the result that we observed from other affinity and mutation studies 
(Ruben Van der Meeren, Pers. information). 
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In the T2SS, the secreted proteins are first transported from the cytoplasm to the periplasm 
through the Tat or Sec inner membrane machineries. The correctly folded and assembled 
exoproteins are then further transported out to the extracellular space via the Xcp machinery. 
Via recognition through the inner membrane platform XcpPC or the secretin XcpQD, the 
exoproteins have to be delivered from the periplasmic space inside the cylindrical 
architecture of the outer membrane XcpQD (Douzi et al., 2012). However, how the assembly 
between XcpPC and XcpQD transits   in  order   to   translocate   the  exoprotein  from  the  “out”   to  
“in”  of  the  cylindrical  architecture  is  still  a matter of debate.  
 
Figure 5.10. The transition interaction model of type II secretion system periplasmic 
domain in Pseudomonas aeruginosa.  The secretin XcpQ channel is closed in the absence of 
XcpP binding, upon the exoprotein appropriate folded in the periplasmic space in example 
with Exotoxin A( PDB: 1IKQ), it drives the binding of XcpP with XcpQ N0 domain together 
with exoprotein, further the channel of secretion XcpQ is open with the XcpP binding to the 
N3 domain, the exoprotein is transported out with the signal of ATPase and the push force 
from the pseudopilins or the retraction of outer membrane secretin XcpQ. 
 
We hypothesize that the XcpPC and XcpQD periplasmic assembly could consist  of  “open”  and  
“closed”   states of the cylindrical architecture to let the exoprotein in. The exoproteins 
reported to interact with both the XcpPC and XcpQD could be followed by the trigger of the 
assembly of the inner membrane platform and the outer membrane secretin. The two distinct 
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interaction interfaces of the XcpPC HR domain to XcpQD N0 and XcpQD N2N3 determined 
by crosslinking may then represent  the  “open”  and  “closed”  state  of  T2SS  in  the  periplasmic 
(Figure 5.10).   However,   how   the   HR   domain   β1   and   β6   are involved in this two states 
binding as described for the E.chrysanthemi Out protein systems remains elusive. Given that 
the XcpQ N1-N2-N3 domains are   connected   with   a   very   flexible   “hinge”   structure,   the  
interaction between XcpPC HR and XcpQD N2N3 can be achieved through the extension of 
the XcpQD “hinge”   between   the N1-N2-N3 domains or a stretch of the XcpP intrinsically 
unstructured protein (IUP) domain between TM and HR domain and the switch binding 
between   β1   or   β6   of   the   HR   domain   caused   rotation.   The   transient interactions are very 
challenging to investigate only with crystallography, especially associated with membrane 
proteins. Molecular Dynamics (MD) simulation and macromolecular docking is a widely 
used technique to obtain information about the time dependent evolution of conformational 
changes and transition (Adcock and McCammon, 2006). We will apply MD simulation and 
macromolecular docking (such as HADDOCK) and integrate the distance restraints that we 
generated from the mass spectrometry based approach to model the possible surface 
interaction of the XcpPC HR domain with XcpQD N0 domain and XcpQD N2N3 domain 
respectively in order to gain further insight about their assemblies (See Chapter two: 
Introduction Section B). 
The in vivo P.aeruginosa crosslink experiments are ongoing and may generate more precise 
physiological level information about the T2SS machinery. 
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5.4 Experimental Procedures 
5.4.1 Protein overexpression and purification 
The P.aeruginosa XcpP and XcpQ protein overexpression and purification were mainly 
carried out by Ruben Van der Meeren with assistance from the author of this thesis. For more 
details, see (Van der Meeren et al., 2013). In general, the DNA of XcpP and XcpQ domains 
were amplified by PCR from genomic DNA using appropriate primers. The PCR product was 
ligated into a pET15b+ expression vector (Invitrogen) using the NdeI and BamHI restriction 
sites. For expression, E. coli BL21(DE3) transformed with pET containing the target DNA 
sequences were grown in LB medium supplied with carbenicillin (100µg/mL) at 37ºC and 
were induced at OD600nm of 0.6-1.0   with   1mM   isopropyl   β-D-1-thiogalactopyranoside 
(IPTG) (Duchefa Biochemie) followed by growth for 5 hours and harvesting by 
centrifugation. The ensuing cell pellet was resuspended (500mM NaCl, 20mM Tris pH 8.0) 
in the presence of protease inhibitors (Complete®, Roche), and were lysed by sonication. The 
cell debris was pelleted by centrifugation at 75,000g for 30 minutes and the supernatant was 
filtered using a syringe filter cap (0.22µm). The clarified lysate was loaded onto a Ni-NTA 
column (Qiagen) pre-equilibrated with buffer A (20mM Tris-HCl pH 8, 500mM NaCl, 
10mM Imidazole), washed with buffer B (20mM Tris-HCl pH 8, 500mM NaCl, 50mM 
Imidazole) and eluted with buffer C (20mM Tris-HCl pH 8, 500mM NaCl, 250mM 
Imidazole). To remove the His6-tag, fractions of purified protein were pooled and 
concentrated on a Vivaspin 15R column 10,000 MWCO (Sartorius Stedim) to ~1mL before 
diluting the sample 10 times with thrombin digestion buffer (150mM NaCl, 20mM Tris pH 8 
and 2.5mM CaCl2). One unit of biotinylated thrombin (Novagen) was added per mL of 
diluted sample and the cleavage reaction was allowed to continue for overnight in the dark at 
room temperature until protein was cleaved completely as evaluated by SDS-PAGE. 
Biotinylated thrombin was removed from solution by adding strepavidin agarose (Novagen) 
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followed by a centrifugation step (10 minutes, 4000 x g) and filtration using a syringe filter 
cap (0.22µm). The sample was subsequently subjected to size exclusion chromatography 
(SEC) on a Superdex-75 column (GE Healthcare) equilibrated with 150mM NaCl, 20mM 
HEPES pH 7.5. Fractions containing pure protein (>95% purity as judged by SDS-PAGE), 
were pooled and concentrated for further study. The concentrations of the samples are 
determined with Nanodrop (Thermo Scientific). 
5.4.2 Chemical Crosslinking, Proteolysis and FTICR 
Crosslinker BS3 or DSS (Pierce) was prepared at a stock concentration of 100 or 200mM in 
water or DMSO respectively. For the crosslinking conditions optimization, different BS3 
concentration 0mM, 0.5mM, 1mM, 2mM and 5mM, the incubation time of 15min, 30min, 
45min, 60min and 120min were used. The 4 degree and room temperature crosslinking 
conditions were also tested and the final crosslinking approach was used as described below. 
A final concentration of 1mM or 2mM of BS3 or DSS was added to the purified protein or 
protein complex (1-2mg/ml) with the final DMSO volume ratio being lower than 2%( for 
DSS). The reaction mixture was incubated at room temperature for 45-60min and then the 
reaction was quenched by the addition of a final concentration of 50mM Tris buffer. The 
sample was subsequently digested overnight at 37 degrees with trypsin (Porcine sequencing 
grade, Promega) using an enzyme to protein ratio of 1:20. The sample was buffer exchanged 
on a Superdex peptide PC 3.2/30 column and the peptides were dissolved in 0.1% FA prior to 
liquid chromatography mass spectrometric (LC-MS) analysis. The digests were analyzed by 
nano LC-MS/MS using an Agilent 1200 HPLC at a flow rate 300nL/min. A C18 
Acclaim PepMap300 5µm column (Thermo Scientific Dionex), trapped the peptides, which 
was followed by a separation on a C18 Acclaim PepMap100 3µm, 75µm×250mm column 
(Thermo Scientific Dionex). Peptides were eluted applying a gradient of acetonitrile with 
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buffer A (0% v/v acetonitrile in 0.1% formic acid) and buffer B (100% v/v acetonitrile in 0.1% 
formic acid). The gradient went from 2%B to 10%B in 10min, from 10%B to 40%B in 30min, 
from 40%B to 80%B in 10min, and back from 80%B to 2%B in 5min. The column outlet was 
directly interfaced via a nanoflow electrospray source (Advion) to an LTQ-FT Fourier 
transform ion cyclotron resonance mass spectrometer (FT-ICR-MS, Thermo). Data 
dependent analysis was carried out using a resolution of 100000 followed by a 10 MS/MS 
spectra scan. MS spectra were acquired over an m/z range of 150-2000, with a charge filter 
above 1; MS/MS scans were applied using threshold energy of 35 eV for collision induced 
dissociation (CID). The chemical crosslink data was submitted to the pLink program for 
analysis of cross-linked peptides (Yang et al., 2012). 
5.4.3 Ion Mobility Mass Spectrometry Analysis 
Purified samples with a protein concentration of 10-20µM were buffer exchanged into 100-
200mM ammonium acetate buffer using Micro Biospin 6 columns (Bio-Rad) just prior to MS 
analysis. The denatured condition was generated with a final concentration of 50% 
acetonitrile in 0.1% formic acid. The ion mobility and mass measurements were carried out 
on a quadrupole ion mobility (IM) TOF MS instrument (Synapt G1 HDMS, Waters, UK) 
equipped with a Nanomate source (Advion).  The buffer exchanged samples were sprayed 
using a capillary voltage of 1.65-1.75 kV. The IM separator was pressurized at 0.5mbar. Data 
were acquired using the traveling waves: ion mobility wave velocity 400-600m/s and a wave 
height 12-15. Ions underwent TOF analysis with an m/z separation range from 1000 to 8000, 
under a vacuum pressure maintained at around 9.5×10-7 mbar. All the other instrument 
parameters were tuned following the protocol reported before (Ruotolo et al., 2008). All the 
data was analyzed under Masslynx V4.1 and DriftScope V2.3 with minimal smoothing and 
background subtraction. 
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General Discussion:  
Conclusion and Perspectives 
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In this PhD thesis, using an integrative structural biology approach, we have provided new 
insights in the molecular mechanism of the Shewanella oneidensis MR-1 HipA-HipB toxin 
antitoxin system and the Pseudomonas aeruginosa type 2 secretion system which are 
involved in bacterial phenomena like persistence and virulence. Despite these efforts, a 
number of questions remain to be clarified. 
 
6.1 What needs still to be done in the study of Shewanella 
oneidensis MR-1 HipA-HipB toxin-antitoxin system molecular 
mechanism? 
(1) The toxin HipA is a Serine/Threonine kinase and in this work, it is proven to have at least 
3 different conformational states, namely apoHipA, ATP Mg2+ bound HipA and 
phosphorylated HipA (pHipA). In vivo verification revealed that E. coli HipA is only 
partially phosphorylated (Correia et al., 2006). We now showed that the intermediate state of 
ATP Mg2+ bound HipA could have a similar conformation as pHipA regardless of 
phosphorylation loop ejection. Both states were observed in the complex of HipA-HipB with 
their operator DNA (ATP Mg2+ bound HipA in E.coli and pHipA in Shewanella oneidensis). 
Recently, concentration threshold-based generation of variability in the toxin-antitoxin 
modules is reported to explain the bistability of persister formation (Cataudella et al., 2013; 
Feng et al., 2014; Gelens et al., 2013; Rotem et al., 2010). The identification of the effective 
population of HipA that is involved in the HipB binding is the key to further develop the 
bistability model. It is crucial to verify which conformational state of HipA is really involved 
in forming the heterocomplex with operator DNA binding thus further results in  
transcriptional suppression. This hypothesis can be further verified with experiments 
including: affinity measurement experiments with pHipA, ATP Mg2+ bound HipA, γ-
phosphatase treated HipA and the HipAD306Q mutant using ITC or SPR techniques; 
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phosphorylation transition rate measurements from apoHipA to ATP Mg bound HipA and 
further phosphorylated HipA using a radioactivity assay. 
 
(2) We have strong evidence that the EF-Tu is also not the substrate of toxin HipA in 
Shewanella oneidensis similar as in E.coli, where recently GltX has been proposed as the 
target of HipA in E.coli as a result of high throughput genetic screening (Germain et al., 
2013; Kaspy et al., 2013). The Shewanella oneidensis and E.coli HipA share only 28% 
identity but act rather similar via a phosphorylation loop ejection mechanism. GltX from 
Shewanella oneidensis and E.coli are highly conserved with more than 90% of identity. It is 
essential to verify whether the GltX is also the substrate of HipA in Shewanella oneidensis. 
HipA overexpression inhibits not only macromolecular synthesis, but also DNA replication 
and transcription (Bokinsky et al., 2013; Korch and Hill, 2006; Korch et al., 2003). Is there 
any other alternative or species-specific substrate rather than GltX? This can be verified by 
producing the Shewanella oneidensis GltX and combine ITC SPR binding experiment, a 
chemical crosslinking mass spectrometry approach, radioactivity assay and structural biology 
techniques such as X-ray crystallography, SAXS. 
 
(3) Besides SO0705-SO0706 studied in depth in this PhD project, the SO0062-SO0063 and 
SO3169-SO3170 are also identified as HipA-HipB toxin antitoxin modules. Hence the 
Shewanella oneidensis MR-1 is the first bacteria reported to have multiple HipA-HipB toxin 
antitoxin modules. It is interesting to study what are the roles of those toxin antitoxin 
modules, to reveal a number of questions: Are there cross reaction between the toxin and 
antitoxin from different modules? Is there redundancy between the three HipA-HipB toxin 
antitoxin systems in terms of biofilm formation and persistence? 
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6.2 Can the HipA-HipB TA system be an antimicrobial drug 
target?  
Iterative cycles of antimicrobial drug discovery are urgently need due to the circumvent the 
almost inevitable selection for MDR and MDT bacteria that arise in clinically settings at 
some point after widespread (ab)use of new antibiotics (Palumbi, 2001; Walsh and 
Wencewicz, 2013). TA modules are an attractive potential target for antimicrobial therapy. 
The speculative strategies of toxin antitoxin systems involved in antimicrobial drug discovery 
has been reported by artificially activating the toxin antitoxin system (Shapiro, 2013; 
Williams and Hergenrother, 2012). However, a limitation to directly target the toxin antitoxin 
systems may be hindered the redundancy of the systems. Therefore, to development broad 
spectrum antimicrobial drugs may be better focusing to upstream and downstream paths of 
the TA systems regulation. For example, most of the type 2 TA systems, the antitoxins are 
reported to be degradated by Clp or Lon protease, hence the Clp or Lon protease could be 
considered as the direct drug target. Indeed, recently it was demonstrated that a combination 
of  conventional antibiotics with a Acyldepsipeptide (ADEP) that could induce the activity of 
ClpP protease, kills both antibiotic sensitive and dormant persister cells (Conlon et al., 2013; 
Gerdes and Ingmer, 2013). Another potential TA module target can be the toxin itself. A 
peptide based on the CcdB toxin which targets the DNA gyrase showed also inhibition effect 
to the bacterial topoisomerase (Trovatti et al., 2008). Further investigation of the molecular 
mechanism with which HipA phosphorylates GltX could also be a source of information to 
perform a rational drug design approach (Lewis, 2013).  
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6.3 How far can we go with a mass spectrometry based integrative 
structural biology approach in the study of type 2 secretion 
system? 
Mass spectrometry based integrative structural biology has developed as a powerful approach 
in the study of macromolecular assembly including membrane associated proteins (Marcoux 
and Robinson, 2013). Most recently, the development of detergent-free mass spectrometry 
technology was established, where intact membrane protein complexes are released in the gas 
phase from amphipols, bicelles and nanodiscs (Hopper et al., 2013). T2SS is a complicated 
multi-subunit membrane associated macromolecular assembly.  At present, the structural and 
functional investigations of such system are not achievable through a single approach; hence 
integrative structural biology endorses its power to study such structures. The mass 
spectrometry based approach has a large advantage in terms of sensitivity and throughput and 
could give different level information to bridge the other technologies. The T2SS can be 
divided into 5 platforms, and native mass spectrometry coupled with Ion Mobility could first 
give an overview of the interaction partners and stoichiometry of the different platforms. The 
further integrative approach that we established for the inter membrane XcpP and outer 
membrane secretin XcpQ using cross-linking mass spectrometry could definitely be applied 
on the other platforms and generate distance restraints both inside each platform and later 
between each platform. The combination of all the information from the mass spectrometry 
platform and data from other techniques such as low resolution Electron Microscopy, Small 
angle X-ray scattering of platform complex and high resolution X-ray crystallography of 
individual subunit, will give a comprehensive structural and functional picture of the T2SS. 
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Summary 
Antibiotics have provided an enormous contribution to humans’ fight against infectious 
microorganisms resulting in a dramatic decrease in mortality due to microbial infections 
around the globe. However, the widespread and uncontrolled use of antibiotics, particularly 
as growth promoters in feedstock caused an environmental stress for bacterial evolution and 
Multi Drug Resistance (MDR) and Multi Drug Tolerance (MDT) are two of the major 
challenges for further eradication of the bacterial infections. In recent years, this antibiotics 
crisis has become one of the most serious public health concerns and threats by renewed 
awareness. Therefore, how the bacteria could survive under the situation of antimicrobial 
treatment and other environmental stress, and how the bacteria infect the host organism are 
essential to develop novel antibacterial strategies. Finding the right strategies such as 
discovery of new antimicrobial drugs are urgent to fight with the current crisis of antibiotic 
therapy.  
In this PhD research, we picked up two major process concerning bacterial infections which 
are bacterial persistence and virulence respectively. Among others, we investigated Toxin-
antitoxin systems of which the recent discovery of new families is one of the most exciting 
molecular microbial phenomena crucial to understand the bacterial behavior. Toxin-antitoxin 
systems are widespread two or three component systems encoded in the bacterial genome and 
highlighted to be involved in the persistence, biofilm formation, pathogenicity, programmed 
cell death and many other cellular processes in bacteria. Due to those characteristics, it also 
has potential as attractive targets in antimicrobial drug discovery. We applied multiple 
structural biology, biochemical and biophysical techniques to explore the molecular 
mechanism of the HipAB toxin-antitoxin system coded in S.oneidensis MR-1 genome, 
involved in biofilm and persistence. Multiple atomic structures including individual HipB as 
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well as complexes of HipA with non-hydrolysable ATP analogues, Mg2+ and HipA-HipB 
with its operator DNA were solved. We showed that phosphorylated HipA can engage in an 
unexpected ternary complex with HipB and double stranded operator DNA that is distinct 
from the prototypical counterpart complex from E.coli. The structure of HipB in complex 
with its operator DNA reveals a flexible C-terminus that is sequestering HipA in the ternary 
complex, indicative of its role in binding HipA to abolish its function in persistence. The 
structure of a HipA mutant devoid of phosphorylation capacity in complex with a non-
hydrolyzable ATP analogue uncovers that HipA autophosphorylation is coupled to an 
unusual conformational collapse of its pLoop. However, HipA is unable to phosphorylate the 
translation factor Elongation factor Tu (EF-Tu), contrary to previous reports but in agreement 
with more recent findings.  Our studies suggest that the phosphorylation state of HipA is an 
important factor in persistence and that the structural and mechanistic diversity of HipAB 
modules as regulatory factors in bacterial persistence is broader than previously thought.  
Aside from the investigation of bacterial persistence, we also study the bacterial secretion 
systems which play a central role in modulating the interactions between the bacteria and its 
host organisms or extracellular environment by secreting diverse virulence factors. We 
focused on the opportunistic human pathogen Pseudomonas aeruginosa type 2 secretion 
system which is one of the most versatile systems used in gram negative bacteria. In 
P.aeruginosa, the T2SS machinery contains 12 protein subunits which can be distinguished 
into 5 subassemblies. Among those 12 protein subunits, XcpP is thought to be tightly 
involved in a procedure that bridges the inner membrane and the outer membrane secretin 
XcpQ; the assembly of XcpP and XcpQ is crucial to understand the transport machinery. We 
carried out multiple mass spectrometry experiments and tightly collaborated with a PhD 
student from Prof. Savvas Savvides’ group, Ruben Van der Meeren focusing on the 
biophysical, biochemical and functional analysis of the assembly between XcpP and XcpQ. 
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We demonstrated that the P.aeruginosa T2SS secretin XcpQ periplasmic domain is a dimeric 
protein which oligomerize into a functional dodecameric assembly with C6 symmetry instead 
of the previous reported dodecameric assembly with C12 symmetry. We proposed the two 
transition states for XcpP and XcpQ periplasmic interaction which consist of  the  “open”  and  
“closed”  state  of  the  Type  2  secretion  system  to  transport  the  exoprotein  from  the  periplasm  
to the extracellular milieu.  Overall, we have successfully applied mass spectrometric based 
integrative structural biology to study the bacterial persistence and virulence.  
The approach combining the biochemical, structural biological, biophysical techniques and 
especially the mass spectrometric based techniques that could bridge those techniques are 
powerful for the structural and functional investigation of supermolecular assembly.  
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Samenvatting 
Antibiotica hebben zeer sterk bijdragen aan de strijd tegen infectieuze micro-organismen en 
de de wereldwijde daling van de mortaliteit  tegen gevolge van microbiële infecties is 
hoofdzakelijk aan hun toepassing te danken. Het wijdverspreide en ongecontrolleerde gebruik 
van deze antibiotica, voornamelijk als groeipromotoren in de dierenvoeding, heeft echter een 
omgevingsstress teweeggebracht die een evolutieve druk als gevolgt heeft waardoor multi-
drug resistentie (MDR) of tolerantie (MDT) steeds vaker de kop op steken.   Dit fenomeen, 
samen met het uitblijven van nieuwe generatie geneesmiddelen, vormt een bedreiging voor 
het verder uitroeien van bacteriële infecties. Deze zgn. antibioticacrisis is een van de 
belangrijkste zorgen voor de volksgezondheid. 
Het is daarom van groot belang om te begrijpen hoe bacteriën kunnen overleven onder 
antimicrobiële  behandeling of andere omgevingsfactoren, alsook hoe de infectie van het 
gastorganisme precies plaatsgrijpt. Dit kan bijdragen tot de ontwikkeling van nieuwe 
strategieën voor antibacteriële behandelingen of het ontwikkelen van nieuwe geneesmiddelen 
zelf.  
Tijdens mijn doctoraatsonderzoek hebben we ons geconcentreerd op twee belangrijke 
processen die betrekking hebben op dergelijke bacteriële infecties, in casu bacteriële 
persistentie en virulentie. Wij onderzochten ondermeer toxine-antitoxinesystemen waarvan 
de recente ontdekking van een paar nieuwe families tot een  van de belangrijkste 
ontdekkingen in de moleculaire microbiologie van de laatste jaren is. Toxine-
antitoxinesystemen zijn wijdverspreide twee-of driecomponentsystemen die door het 
bacteriële genoom gecodeerd worden. Ze zijn betrokken bij diverse fenomenen waaronder 
persistentie, biofilmvorming, pathogeniciteit, geprogrammeerde celdood en andere cellulaire 
processen. Gezien hun belang voor de levenswijze van de bacterie worden gezien als ze een 
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attractieve alternatieve target in antimicrobiele geneesmiddelenontwikkeling. Wij pasten een 
waaier van structureel biologische, biochemische en biofysische methoden toe om het 
moleculaire mechanisme van HipAB toxine-antitoxine systeem gecodeerd in genoom van het 
modelorganisme Shewanella oneidensis MR-1 genome te begrijpen. We losten verschillende 
atomaire structuren op, waaronder die van het individuele HipB, gefosforyleerd HipA alsook 
complexen van HipA met niet-hydrolyseerbare ATP analogen en met HipB zelf. Ook de 
structuur van het HipA-HipB complex met het  operator DNA werd opgehelderd. We 
toonden aan dat gefosforyleerd HipA kan betrokken worden in een overwacht ternair 
complex met HipB en dubbelstrengig operator DNA dat afwijkt van het prototypische model 
bekomen bij de structuuropheldering van het E.coli HipAB.  De structuur van het HipB in 
complex met operator DNA geeft een flexibele C-terminus weer die HipA kan vasthouden in 
een ternair complex. Dit bevestigt de rol van HipB dat HipA bindt om te verhinderen dat het 
zijn functie in persistentie kan uitvoeren.  De structuur van een HipA mutant die niet in staat 
is om te autofosforyleren, in complex met niet-hydrolyseerbare ATP analogen geeft aan dat 
HipA autofosforylatie is gekoppeld aan een ongewone conformationele veraandering van 
haar pLoop. We toonden aan dat, in tegenstelling tot wat oorspronkelijk beschreven was voor  
E.coli HipA dat het S.oneidensis eiwit niet in staat is om de elongatiefactor TU (EF-TU) te 
fosforyleren. Onze studie suggereert verder dat de gefosforyleerde toestand van HipA 
belangrijk is voor persistentie en dat de structurele en mechanistische diversiteit van HipAB 
modules als regulatore van persistentie groter is dan oorspronkelijk gedacht.  
Naast de studie van de moleculaire mechanismen van de inductie van bacteriële persistentie 
hebben wij ook een studie gedaan van de moleculaire componenten die betrokken zijn bij 
bacteriële secretie. Deze secretiesystemen spelen een central rol in het moduleren van de 
interacties tussen de bacterie en haar gastheerorganisme of de extracellulaire omgeving en 
exporteren diverse virulentiefactoren naar de omgeving. We hebben ons toegespitst op de 
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opportunistische humane pathogen Pseudomonas aeruginosa en haar type 2 secretiesysteem 
(T2SS) dat model staat voor een van de meest voorkomende systemen in gram negatieve 
bacteriën. In P.aeruginosa bevat de T2SS machinerie 12 eiwitsubeenheden die kunnen 
onderverdeeld worden in 5 subassemblages. Bij deze twaalf subeenheden is XcpP een 
belangrijke subeenheden omdat die betrokken is bij de overbrugging tussen de binnenste en 
de buitenste membraan waar het interageert met het secretine XcpQ. Een goed begrip van het 
complex tussen XcpP en XcpQ is cruciaal om de transportmachinerie te begrijpen. We 
hebben diverse massaspectrometrische experimenten uitgevoerd, en hierbij nauw 
samengewerkt met een andere doctoraatstudent, Ruben Van der Meeren uit de groep van Prof. 
Savvas Savvides. We hebben aangetoond dat het T2SS secretine XcpQ periplasmatische 
domein een dimeer is, die oligomerizeert tot een functionele dodecameer met C6 symmetrie 
in plaats van een dodecameer met C12 symmetrie zoals voorheen gerapporteerd. We stelden 
een model op dat die twee transititetoestanden voor de interactie van de periplasmatische 
domeinen   van   XcpP   en   XcpQ,   die   een   “open”   en   een   “gesloten”   toestand   van het T2SS 
secretiesysteem inhouden.   
Globaal gezien hebben wij voornamelijk gebruik gemaakt van massaspectrometrische 
technieken, en tonen aan hoe deze methoden in het portfolio van biochemische, structureel 
biologische en biofysische methoden voor de karakterisatie van eiwitstructuren kunnen 
worden ingezet. Dit draagt bij tot een integratieve en multidisciplinaire aanpak van het 
onderzoek naar de werking van eiwitten in het algemeen. 
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